TSS:Rfhg 57635.1

Basic information about the TSS

---

TSS ID: rfhg_57635.1 Species: human Chr: chr4		Start: 48805139 End: 48805170 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000504654.5:42 GeneID: 54940 HGNC/MGI_ID: HGNC:16074 UniProt_ID: D6RA54 Nearer transcript ids and distances:

Gene_name: FRYL Gene_symbol: OCIAD1 Gene_synonyms: Asrij FLJ20455 OCIA TPA018 Gene_source: HGNC:16074

TATA-Box annotation

---

Distance to TSS:	-24855
Nearest PromoterID:	NM_015030
Entrez ID:	285527
Nearest Unigene:	Hs.595553
Nearest Refseq:	NM_015030
Nearest Ensembl:	ENSG00000075539
Gene Name:	FRYL
Gene Alias:	AF4p12|KIAA0826|MOR2
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.437500
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@OCIAD1 p2@OCIAD1 p3@OCIAD1 p4@OCIAD1 p5@OCIAD1 p6@OCIAD1 p7@OCIAD1 p8@OCIAD1 p9@OCIAD1 p10@OCIAD1
Sample		p1@OCIAD1	p2@OCIAD1	p3@OCIAD1	p4@OCIAD1	p5@OCIAD1	p6@OCIAD1	p7@OCIAD1	p8@OCIAD1	p9@OCIAD1	p10@OCIAD1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	31.95	16.75	8.96	5.45	10.71	1.95	2.14	2.14	0.39	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	29.94	14.36	9.71	4.65	10.93	3.44	3.24	1.42	0.40	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	31.64	14.66	10.03	6.56	11.00	1.93	2.70	0.77	0.19	0.39
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	28.07	11.64	7.48	6.65	8.11	2.08	4.16	1.25	0.21	0.42
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	26.10	17.10	7.87	4.27	10.12	4.72	2.02	2.47	0.90	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	29.07	10.66	6.40	4.85	11.63	1.55	3.10	1.74	0.19	0.58
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	44.67	21.57	13.73	8.72	13.73	5.66	2.40	1.96	0.44	1.31
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	38.76	15.26	12.35	5.57	14.29	6.30	1.94	1.70	0.48	0.48
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	28.00	13.46	11.54	5.13	8.76	3.21	3.21	1.28	0.43	1.28
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	30.72	11.01	15.07	4.06	19.13	6.96	1.74	2.90	0.58	1.16
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	31.53	7.68	19.40	7.28	18.19	5.66	2.02	2.43	0.81	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	33.34	8.94	15.04	2.03	16.67	8.54	0.81	3.25	1.22	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	46.58	37.07	8.87	4.51	0.48	0.16	1.61	2.10	0.32	1.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	38.64	37.59	10.37	6.01	0.90	0.45	1.20	1.80	0.45	1.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	45.01	34.25	11.64	6.37	1.10	0.66	2.20	2.42	0.44	2.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	48.29	35.71	8.30	5.28	0.75	0.25	1.76	2.51	0.00	1.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	46.30	37.57	7.21	6.33	0.66	0.22	2.40	0.66	0.44	2.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	40.92	38.81	6.33	5.48	1.27	0.00	1.69	0.00	0.00	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	44.25	44.78	7.46	9.06	1.07	0.53	1.60	1.07	0.53	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	44.38	32.50	8.42	5.12	0.30	0.60	1.35	2.56	0.45	2.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	38.49	33.95	6.82	5.75	0.40	0.27	1.47	1.47	0.27	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	41.26	38.67	7.42	6.21	0.69	0.00	1.38	1.38	1.04	2.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	44.72	39.42	8.53	4.91	1.03	0.13	2.46	0.90	0.39	1.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	40.04	35.43	7.52	9.46	0.97	0.24	2.43	1.46	0.24	0.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	43.08	34.57	6.45	6.45	0.52	0.26	1.29	0.52	0.26	1.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	34.82	33.23	6.33	4.75	0.95	0.63	2.53	1.58	0.32	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	49.45	46.15	8.24	10.44	1.65	1.10	3.85	2.20	0.00	2.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	49.04	39.37	11.08	6.13	1.18	0.47	0.94	2.59	0.94	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	36.67	35.37	9.85	5.01	1.45	0.81	1.29	1.94	0.48	1.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	43.97	35.83	12.49	6.15	0.54	0.54	0.90	1.09	1.09	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	41.03	37.68	6.91	6.49	1.88	0.21	1.67	1.26	0.42	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	42.40	35.17	5.86	6.45	1.37	0.20	1.95	1.76	0.39	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	47.27	43.68	7.60	7.39	1.27	0.84	2.53	2.32	0.63	2.74
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	70.76	64.16	10.06	10.56	1.48	0.49	1.98	2.31	0.33	1.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	46.37	40.76	9.35	7.85	0.93	0.00	1.12	2.24	0.56	2.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	45.99	40.05	8.05	6.52	0.77	0.19	1.53	1.92	0.38	1.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	45.37	34.13	9.81	5.31	0.61	0.82	1.02	1.84	0.41	2.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	47.55	34.86	5.24	7.25	0.20	0.20	2.22	1.01	0.81	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	49.16	33.76	9.45	7.56	0.54	0.54	1.62	2.16	0.27	1.08
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	43.45	33.37	8.64	5.04	1.20	0.48	1.92	1.68	0.48	1.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	39.99	35.52	8.94	7.29	0.47	0.71	1.65	2.82	0.71	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	50.36	45.09	10.54	8.64	0.88	1.02	2.64	2.20	0.29	1.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	46.19	36.27	7.17	6.33	1.05	0.42	1.48	2.53	0.21	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	42.48	39.16	8.57	4.02	0.52	0.17	1.92	1.57	0.52	0.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	42.97	32.32	8.63	6.22	1.81	1.20	0.80	2.21	0.40	2.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	39.32	31.41	10.24	5.12	0.23	2.09	2.56	1.63	0.23	2.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	38.39	30.47	6.00	5.04	0.00	0.72	1.44	1.68	0.48	1.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	42.92	29.51	5.66	6.86	1.19	0.60	0.60	1.79	0.60	1.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	36.62	35.19	5.03	6.22	0.96	0.96	0.72	1.91	0.48	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	37.41	33.97	5.86	5.86	0.81	0.40	2.02	1.01	0.20	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	48.16	32.79	7.79	5.33	0.61	0.61	2.46	2.46	0.41	2.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	44.25	30.02	10.23	5.11	1.11	0.67	1.78	2.00	0.22	2.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	125.93	139.92	27.98	13.99	0.00	0.00	0.00	0.00	13.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	31.94	19.52	3.19	1.06	2.48	0.00	2.84	2.48	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	29.49	24.52	5.30	5.96	0.66	0.99	0.99	1.99	0.00	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	157.72	142.62	19.30	15.10	1.68	2.52	5.87	10.91	1.68	4.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	80.83	59.70	11.02	9.18	3.67	0.92	1.84	3.67	0.46	4.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	35.98	29.82	7.45	4.21	1.62	0.00	0.32	1.94	0.00	2.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	30.51	25.05	2.89	3.53	0.64	0.32	2.25	1.28	0.00	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	96.81	54.38	12.89	6.29	2.83	1.26	0.94	5.34	0.00	1.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	31.02	18.33	4.23	5.64	2.12	0.00	1.41	0.00	0.71	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	24.11	24.11	8.41	1.12	0.56	0.00	2.24	1.68	0.56	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	130.57	82.00	14.33	4.78	3.98	0.00	0.80	8.76	0.80	3.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	75.77	46.21	9.51	3.74	2.72	0.00	1.02	3.06	0.34	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	49.71	31.52	3.57	5.52	1.95	0.00	1.62	4.87	0.00	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	31.24	23.07	4.61	1.77	0.35	0.71	1.06	1.06	0.35	1.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	96.98	113.15	16.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	142.15	110.56	39.49	7.90	0.00	0.00	7.90	7.90	0.00	15.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	26.81	19.99	5.36	1.46	1.95	0.00	0.98	0.98	0.00	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	33.22	17.36	6.45	5.45	0.99	0.00	0.50	0.50	0.00	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	25.80	16.89	6.57	2.81	0.00	0.00	2.35	0.47	0.94	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	85.78	32.46	7.95	3.64	0.66	0.00	1.66	4.64	0.00	1.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	34.65	19.80	1.24	5.26	0.93	0.00	1.86	2.78	0.31	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	38.22	15.29	3.67	4.59	0.61	0.00	1.53	1.22	0.00	0.00
Adipocyte - breast, donor1	11376-118A8	38.17	31.68	11.09	7.44	2.06	0.79	2.38	1.27	1.43	0.79
Adipocyte - breast, donor2	11327-117E4	40.75	22.14	10.43	6.10	1.60	0.48	0.96	1.44	0.64	1.76
Adipocyte - omental, donor1	11473-119C6	53.82	34.10	17.68	8.40	1.78	1.53	1.65	1.91	0.89	0.76
Adipocyte - omental, donor2	11474-119C7	44.85	27.66	10.46	8.97	2.24	2.99	0.75	0.75	0.75	0.75
Adipocyte - omental, donor3	11475-119C8	25.79	27.46	13.40	4.35	3.68	1.34	1.00	1.34	0.67	0.33
Adipocyte - perirenal, donor1	11476-119C9	36.37	33.18	19.14	8.29	0.64	1.91	1.91	0.64	0.64	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	13.19	6.60	2.20	3.30	1.10	1.10	0.00	2.20	0.00	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	33.42	23.94	12.19	5.42	2.71	0.90	0.90	0.90	1.81	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	31.28	21.90	12.34	3.30	0.52	1.22	0.70	0.87	1.04	0.70
Adipocyte differentiation, day04, donor1	13019-139D4	41.46	35.99	16.04	7.24	0.39	0.59	1.37	0.39	1.37	0.98
Adipocyte differentiation, day04, donor2	13022-139D7	27.02	22.13	14.67	6.95	2.06	0.77	1.03	0.51	1.03	0.77
Adipocyte differentiation, day04, donor3	13025-139E1	29.55	24.25	12.82	5.30	1.12	0.56	0.28	0.84	1.39	1.39
Adipocyte differentiation, day04, donor4	13028-139E4	30.57	27.04	14.70	5.88	0.59	0.59	1.76	0.00	2.35	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	47.70	41.50	10.05	7.24	1.45	0.97	1.37	1.69	0.88	1.05
Adipocyte differentiation, day08, donor2	13023-139D8	29.69	30.98	9.36	6.13	0.32	1.61	0.65	0.32	0.97	0.65
Adipocyte differentiation, day08, donor3	13026-139E2	32.52	17.60	6.93	3.20	1.07	0.53	1.07	1.60	1.07	1.60
Adipocyte differentiation, day08, donor4	13029-139E5	36.17	31.72	13.91	6.12	0.56	0.56	1.11	1.11	0.56	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	32.44	26.20	13.72	6.24	0.83	0.83	1.25	2.50	0.00	0.83
Adipocyte differentiation, day12, donor2	13024-139D9	27.88	29.89	10.05	6.28	0.50	0.75	1.00	0.75	0.50	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	35.67	21.93	6.87	4.58	1.96	0.00	0.98	1.96	0.98	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	30.75	25.58	11.87	3.04	0.91	0.30	0.61	2.13	1.22	0.91
Alveolar Epithelial Cells, donor1	11510-119G7	30.06	14.36	3.09	3.54	1.99	0.66	0.66	1.10	0.00	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	8.61	4.30	0.00	0.36	0.00	0.00	0.00	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	9.58	4.79	3.59	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	28.60	17.45	5.58	2.70	1.26	0.72	0.36	0.54	0.00	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	16.73	16.73	5.02	3.35	1.67	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	18.70	15.82	3.70	3.70	0.41	0.21	0.82	0.00	0.21	0.21
Anulus Pulposus Cell, donor1	11248-116E6	60.42	40.51	28.95	7.78	0.80	1.26	2.06	0.80	1.60	1.60
Anulus Pulposus Cell, donor2	11463-119B5	32.57	31.84	24.49	6.86	0.98	0.49	1.47	0.73	1.47	0.98
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	36.84	20.67	17.97	3.59	2.70	1.35	4.49	1.35	0.90	1.80
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	49.06	30.82	16.06	5.64	1.74	1.74	2.17	2.60	0.87	0.87
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	14.98	17.12	8.56	4.28	0.00	0.00	0.00	4.28	4.28	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	42.15	26.31	14.65	6.28	1.20	1.49	2.09	1.20	0.90	1.79
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	56.91	27.82	16.44	5.06	1.26	1.26	1.26	1.26	0.00	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	24.42	18.48	7.26	4.62	0.66	0.00	1.98	3.30	0.66	1.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	37.69	19.49	15.27	5.85	1.30	0.97	1.30	0.97	0.65	1.62
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	38.84	28.64	20.39	6.80	1.94	1.46	2.91	0.49	0.00	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	34.44	20.19	12.47	4.75	1.19	0.00	1.78	1.19	0.00	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	49.72	22.97	11.30	7.16	2.64	0.00	1.51	1.88	1.88	2.64
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	50.80	23.22	11.61	2.90	1.45	0.00	1.45	0.00	0.73	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	21.31	17.55	11.28	6.27	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	47.61	23.56	12.68	8.24	2.14	0.33	1.81	1.48	0.99	0.99
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	43.67	19.11	15.01	4.09	0.00	1.36	0.00	0.00	0.00	2.73
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	37.55	17.04	12.52	4.52	2.41	0.45	1.81	1.81	1.06	0.45
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	40.18	21.97	11.79	3.75	2.14	0.54	0.54	1.61	1.61	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	40.62	18.89	12.09	4.16	0.76	0.76	0.76	1.13	0.94	1.70
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	40.36	17.37	14.43	5.08	1.07	0.00	1.60	1.87	0.80	1.34
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	41.94	23.41	5.85	5.85	0.98	0.98	0.00	0.98	0.00	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	42.29	14.43	11.44	5.31	2.32	1.16	1.82	0.66	0.33	1.16
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	31.22	9.61	8.41	0.00	1.20	0.00	1.20	2.40	1.20	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	38.94	14.16	7.08	7.08	7.08	0.00	0.00	0.00	3.54	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	38.25	20.07	10.46	7.38	1.37	0.86	1.37	0.69	0.86	0.51
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	16.78	0.00	8.39	0.00	4.19	0.00	0.00	0.00	4.19	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	30.10	24.27	21.84	5.34	1.94	1.46	2.43	1.94	0.97	2.43
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	44.78	19.35	10.62	4.17	3.04	0.38	1.90	2.28	1.14	1.52
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	37.55	16.96	13.33	6.06	0.00	1.21	1.21	1.21	0.00	2.42
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	35.91	32.49	11.40	5.70	1.14	1.14	2.85	3.99	0.00	1.14
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	31.64	16.46	14.54	4.92	1.28	0.64	1.92	0.86	1.28	1.28
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	24.52	17.03	10.32	3.61	1.29	0.52	2.58	0.00	0.52	1.55
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	42.70	15.95	12.20	7.98	0.94	0.47	2.35	0.94	0.47	0.94
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	35.05	18.33	10.61	3.22	2.25	0.64	0.64	0.96	2.25	1.29
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	31.39	14.27	5.71	4.28	2.14	0.00	1.43	1.43	0.00	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	31.59	20.47	13.45	3.51	2.34	0.00	2.34	0.00	1.75	1.75
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	37.03	19.57	10.84	4.82	1.81	0.60	1.51	0.90	0.30	0.60
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	33.26	10.69	9.50	4.75	1.19	1.19	1.19	1.19	0.00	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	43.23	28.48	18.31	4.58	1.53	0.51	3.56	2.54	0.51	1.53
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	36.68	23.43	11.21	6.11	1.53	1.78	2.29	1.78	0.51	2.80
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	27.96	12.07	10.80	6.99	1.27	0.64	2.54	1.27	0.64	1.91
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	37.11	20.28	10.36	5.18	0.00	0.86	3.02	0.43	1.29	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	38.10	16.93	11.64	6.77	1.48	1.06	1.69	1.27	0.85	1.06
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	28.42	16.24	13.92	4.93	0.00	0.29	2.61	0.87	0.58	1.16
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	43.46	12.28	8.50	5.67	0.00	0.00	0.94	0.00	1.89	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	34.24	19.83	12.54	4.75	1.53	0.68	1.19	1.02	0.34	0.85
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	23.16	13.90	11.58	2.32	2.32	0.00	0.00	2.32	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	46.48	27.46	12.68	6.34	2.11	2.11	2.11	0.00	2.11	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	32.59	14.37	10.72	4.29	1.29	1.07	2.14	1.29	0.21	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	41.51	14.44	9.63	5.41	3.01	0.00	0.60	1.20	1.20	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	33.53	26.97	16.04	7.29	2.19	0.73	1.46	0.73	1.46	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	37.93	17.70	13.79	5.98	1.38	1.61	1.38	1.61	0.23	1.38
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	38.25	33.15	17.85	5.10	2.55	2.55	2.55	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	35.85	18.05	16.78	5.85	2.03	0.76	1.02	1.78	1.02	1.27
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	35.92	19.82	11.97	4.54	2.27	1.24	3.10	0.62	1.03	1.65
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	26.93	17.44	10.71	4.90	0.92	0.92	1.22	0.92	0.00	1.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	46.85	29.16	19.12	4.30	5.26	0.96	1.91	1.43	0.00	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	34.15	22.62	13.53	6.43	1.33	0.67	1.55	1.55	1.77	1.33
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	25.94	18.31	15.26	1.53	3.05	1.53	3.05	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	33.23	23.26	11.63	6.09	1.66	0.55	4.98	1.66	0.55	1.11
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	36.01	19.59	11.39	3.71	1.32	0.00	2.12	1.32	0.26	0.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	27.62	16.72	13.45	5.45	2.18	0.00	1.09	1.82	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	41.14	28.37	8.47	8.84	0.74	0.61	1.35	0.61	0.74	0.37
Astrocyte - cerebellum, donor2	11580-120F5	25.50	21.22	6.50	1.88	0.17	0.68	0.34	0.17	0.17	0.17
Astrocyte - cerebellum, donor3	11661-122F5	18.46	13.84	4.61	3.36	0.84	0.63	1.26	0.42	0.21	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	45.32	46.36	15.69	10.46	4.18	3.83	0.70	2.44	2.09	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	46.43	32.19	16.02	7.44	2.59	1.78	2.75	2.75	1.62	1.62
Astrocyte - cerebral cortex, donor3	11392-118C6	49.37	29.09	9.99	6.26	1.64	1.94	1.64	2.39	1.49	0.30
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	79.36	27.30	12.73	7.45	0.69	1.15	2.75	6.42	0.57	3.10
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	74.79	27.81	11.02	6.89	1.63	2.76	2.63	3.13	1.50	1.75
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	77.61	27.65	11.15	7.74	0.80	1.48	1.93	4.21	1.25	1.82
Basophils, donor1	12241-129G9	24.58	23.01	8.63	2.62	0.26	2.09	0.78	0.52	0.52	0.00
Basophils, donor2	12242-129H1	30.67	33.19	17.68	6.86	1.44	6.86	2.16	0.72	1.08	0.00
Basophils, donor3	12243-129H2	24.99	23.81	7.35	3.38	0.73	2.20	1.32	0.15	0.59	0.73
Bronchial Epithelial Cell, donor1	11511-119G8	35.14	12.07	1.72	3.23	0.86	0.22	0.22	0.22	0.22	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	7.31	4.11	0.46	0.46	0.00	0.00	0.46	0.46	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	35.87	7.17	7.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	24.48	6.28	2.51	3.77	2.51	0.00	0.00	1.26	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	16.43	6.24	1.25	2.29	1.04	0.00	0.21	0.62	0.21	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	24.18	8.29	3.45	2.76	0.23	1.15	0.23	0.46	0.46	0.46
Bronchial Epithelial Cell, donor7	11769-123I5	49.13	18.89	6.48	5.22	1.80	0.18	0.72	2.16	1.08	1.08
Burkitt's lymphoma cell line:DAUDI	10422-106C8	66.68	19.48	6.49	5.67	0.93	0.82	1.03	1.55	0.21	1.24
Burkitt's lymphoma cell line:RAJI	10476-106I8	86.17	34.70	6.75	9.08	1.86	0.93	2.56	2.56	0.70	1.40
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	75.15	72.27	27.82	9.59	0.64	1.92	1.28	0.96	0.32	0.96
CD133+ stem cells - cord blood derived, pool1	12223-129E9	82.74	93.08	31.03	20.68	0.00	10.34	10.34	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	20.85	19.72	7.33	2.82	0.56	1.69	1.13	1.13	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	20.97	16.33	7.05	2.41	0.56	0.37	0.37	0.00	1.11	0.00
CD14+ Monocytes, donor3	11381-118B4	17.78	16.90	8.12	1.98	0.88	1.32	1.98	0.66	0.44	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	44.44	40.48	9.91	5.09	0.28	0.57	0.57	2.55	0.85	1.42
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	47.38	32.98	10.99	5.31	0.00	0.00	0.38	0.38	0.38	1.90
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	37.48	26.30	8.88	6.57	0.33	0.00	0.99	1.31	0.66	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	25.87	23.27	9.68	4.34	0.58	0.72	1.16	0.72	0.87	0.58
CD14+ monocytes - mock treated, donor2	11873-125C1	19.31	19.61	7.85	2.41	0.91	1.81	1.21	0.60	0.00	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	26.06	16.82	9.48	2.84	0.95	1.18	0.71	0.47	0.24	0.71
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	17.91	11.72	6.86	3.35	0.33	0.50	0.50	0.67	0.50	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	16.28	12.14	5.80	1.38	0.55	2.21	0.00	0.55	0.55	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	19.09	13.88	8.43	2.73	0.74	1.98	0.74	1.49	0.50	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	15.47	16.06	10.18	2.35	0.00	1.17	0.59	0.20	0.20	0.20
CD14+ monocytes - treated with BCG, donor2	11870-125B7	23.15	14.96	6.05	2.49	0.18	0.89	1.25	0.36	0.36	0.53
CD14+ monocytes - treated with BCG, donor3	11880-125C8	26.33	18.06	11.32	2.39	0.44	2.83	1.09	0.00	0.44	0.65
CD14+ monocytes - treated with Candida, donor1	11868-125B5	22.24	11.94	8.43	1.64	0.47	0.94	1.87	0.94	0.23	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	23.23	15.84	12.14	1.06	0.00	1.58	1.06	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	26.62	22.19	5.55	2.22	1.11	1.11	1.11	0.00	0.00	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	22.01	17.25	9.82	2.97	0.00	0.74	0.59	1.34	0.30	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	21.35	15.37	9.18	3.19	0.00	1.40	0.40	0.60	0.00	0.40
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	29.15	24.15	9.58	2.50	0.42	2.50	0.62	0.83	0.83	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	22.88	16.47	7.55	2.97	0.92	1.37	0.23	0.46	0.23	0.23
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	22.39	16.29	6.33	1.13	0.45	1.81	0.68	0.68	0.68	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	21.82	12.66	9.17	3.06	0.00	1.31	0.44	0.87	0.00	0.87
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	24.21	16.68	8.07	4.03	0.27	1.61	0.54	0.27	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	25.47	21.11	9.07	2.27	0.52	1.22	0.52	0.52	0.35	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	29.46	17.25	10.52	3.79	0.84	3.79	0.84	2.52	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	20.39	15.06	8.82	2.39	0.37	1.29	0.55	0.18	0.18	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	12.68	11.62	10.92	1.76	1.06	3.87	0.00	1.76	0.70	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	23.25	8.77	9.65	2.19	1.32	1.32	0.88	0.88	0.44	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	20.75	14.30	6.80	2.09	0.00	1.22	0.52	0.87	0.17	0.52
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	18.58	13.38	4.83	2.23	0.37	0.74	1.86	0.74	1.12	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	33.19	17.89	9.05	2.16	0.65	3.02	0.43	0.65	0.22	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	18.43	11.88	4.91	2.05	0.00	0.82	0.82	0.82	1.23	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	22.48	10.43	7.19	1.62	1.16	1.62	0.23	0.70	0.46	0.46
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	28.07	13.69	6.26	1.39	0.93	1.62	1.39	0.46	0.70	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	47.73	34.87	9.37	5.45	0.44	0.00	1.96	0.44	0.00	0.22
CD14+CD16+ Monocytes, donor2	11801-124D1	47.12	48.05	8.32	7.62	0.69	0.69	1.85	1.62	0.23	0.46
CD14+CD16+ Monocytes, donor3	11912-125G4	49.17	45.06	8.23	7.15	0.22	0.00	2.17	0.87	0.00	0.65
CD14+CD16- Monocytes, donor1	11788-124B6	57.62	52.48	7.94	8.10	0.16	0.00	1.25	0.93	0.47	0.93
CD14+CD16- Monocytes, donor2	11799-124C8	56.24	39.29	6.64	6.64	0.35	0.00	0.87	0.52	0.35	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	57.08	36.34	10.48	4.46	0.00	0.45	0.67	1.34	0.00	0.89
CD14-CD16+ Monocytes, donor1	11790-124B8	40.83	46.70	8.42	6.12	0.26	0.00	1.79	1.28	0.00	0.51
CD14-CD16+ Monocytes, donor2	11800-124C9	50.28	49.62	8.34	5.93	0.22	0.00	0.88	0.88	0.66	2.20
CD14-CD16+ Monocytes, donor3	11911-125G3	45.69	43.16	6.95	6.74	0.42	0.42	1.26	1.05	0.42	0.42
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	85.36	111.78	8.13	14.23	0.00	0.00	6.10	2.03	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	96.95	80.68	6.78	14.92	0.68	0.00	3.39	0.68	0.68	2.03
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	82.85	70.42	13.46	15.53	0.00	0.00	3.11	4.14	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	77.82	72.49	15.99	13.33	0.00	0.00	1.07	1.60	0.53	1.60
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	93.81	102.39	16.08	17.15	0.00	1.07	2.68	0.00	2.14	2.14
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	86.34	89.85	4.21	9.83	0.70	0.00	0.70	1.40	0.70	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	87.85	87.06	13.33	11.77	1.57	0.00	0.78	0.78	0.78	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	100.19	89.64	11.86	17.14	1.32	0.00	1.32	1.32	2.64	1.32
CD19+ B Cells, donor1	11544-120B5	37.81	50.96	10.68	4.93	0.82	1.64	1.64	0.00	0.00	0.82
CD19+ B Cells, donor2	11624-122B4	31.19	35.55	18.14	1.45	0.00	0.73	1.45	0.00	1.45	0.73
CD19+ B Cells, donor3	11705-123B4	38.37	31.30	13.13	6.56	0.00	1.01	0.50	1.51	1.01	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	118.79	62.63	12.53	7.68	2.42	1.62	0.40	7.27	1.21	1.62
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	79.90	41.15	13.98	7.19	0.40	1.60	1.60	5.59	1.20	0.40
CD34+ Progenitors, donor1	11545-120B6	27.11	38.15	18.07	7.03	0.00	2.01	1.00	0.00	0.00	1.00
CD34+ Progenitors, donor2	11625-122B5	36.52	43.26	41.01	3.37	2.81	2.25	3.37	0.00	1.12	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	67.64	55.99	17.28	8.27	0.00	1.13	1.50	2.25	1.13	0.75
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	80.72	64.71	22.77	10.37	1.80	0.90	2.25	1.58	2.25	1.35
CD4+ T Cells, donor1	11225-116C1	48.56	55.34	14.64	11.43	2.14	3.21	1.43	0.00	2.50	0.36
CD4+ T Cells, donor2	11306-117C1	40.42	39.19	23.88	5.51	1.22	1.22	2.45	1.22	1.84	0.00
CD4+ T Cells, donor3	11382-118B5	34.46	36.90	18.91	5.79	0.61	0.61	2.74	1.22	0.61	0.61
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	54.62	73.76	10.72	12.76	0.51	0.26	1.79	1.28	0.26	1.28
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	50.31	58.62	9.88	9.88	1.12	0.00	1.12	0.90	0.45	0.90
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	55.48	56.34	9.49	10.35	0.29	0.29	1.44	2.30	0.57	0.57
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	99.09	114.26	15.17	18.96	0.47	0.47	1.42	2.84	1.42	0.95
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	108.16	120.80	16.86	23.18	2.81	1.40	2.11	2.81	0.70	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	72.52	65.92	19.78	29.67	0.00	3.30	0.00	3.30	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	53.76	55.78	13.15	15.03	0.43	0.43	2.17	1.88	0.29	2.46
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	37.45	38.81	9.32	8.13	0.17	0.34	2.37	2.37	0.17	1.53
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	37.40	40.79	6.45	7.58	0.00	0.00	1.77	0.81	0.00	0.32
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	69.04	62.76	14.35	9.41	0.45	1.34	1.79	0.90	0.45	0.90
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	64.64	73.37	16.77	17.12	1.05	0.00	2.10	0.35	0.70	1.40
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	60.28	63.36	13.64	10.56	0.44	1.32	2.20	1.32	0.00	0.88
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	66.20	53.97	13.49	14.34	0.84	0.42	0.84	2.11	0.42	0.84
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	36.78	46.96	7.48	8.93	0.21	0.00	2.08	1.25	0.62	1.66
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	48.78	36.42	10.36	11.36	0.33	0.00	0.67	2.67	0.67	1.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	107.14	85.39	23.93	17.68	2.18	0.54	2.72	1.90	0.82	1.63
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	112.01	107.19	20.90	16.08	0.54	1.07	2.14	2.14	0.54	3.75
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	77.11	50.21	14.35	3.59	1.79	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	67.68	55.26	13.72	12.61	1.30	0.56	1.11	1.67	0.56	0.56
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	44.41	49.17	9.10	11.48	0.65	0.00	1.73	1.95	0.65	0.65
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	44.13	39.72	7.99	9.46	0.84	0.63	1.26	1.89	1.26	1.26
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	90.00	65.22	16.18	13.15	2.02	0.00	1.01	3.03	0.00	1.01
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	82.32	71.05	15.16	12.13	0.43	0.43	1.30	2.60	1.30	1.30
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	86.29	63.63	18.74	10.90	1.74	0.87	0.87	0.87	0.87	2.18
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	99.96	110.36	19.30	25.24	0.49	0.49	2.97	2.47	1.48	3.46
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	106.17	96.01	13.85	20.31	0.00	0.00	4.62	0.92	0.00	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	86.54	110.27	20.94	29.31	0.00	0.00	1.40	4.19	1.40	6.98
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	110.77	104.68	25.75	24.65	1.11	0.55	3.60	3.60	1.38	1.94
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	122.70	120.00	22.09	23.07	0.25	0.74	3.44	2.70	0.98	1.47
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	97.02	72.38	18.48	15.40	0.00	0.00	1.54	1.54	1.54	3.08
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	100.63	79.50	20.77	18.98	0.00	0.36	3.22	1.79	0.00	1.43
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	102.49	85.87	12.46	23.54	0.00	0.00	1.38	1.38	1.38	1.38
CD8+ T Cells, donor1	11226-116C2	32.08	36.67	14.41	9.82	4.26	6.55	3.93	0.33	0.65	0.00
CD8+ T Cells, donor2	11307-117C2	18.77	18.77	12.76	7.13	0.75	5.63	3.00	0.00	1.50	0.38
CD8+ T Cells, donor3	11383-118B6	36.11	32.07	16.66	6.06	1.26	4.80	4.04	0.25	1.51	1.26
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	16.97	23.63	9.41	6.42	3.90	1.15	2.06	1.38	0.46	0.46
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	18.93	22.29	6.23	3.83	2.88	0.96	1.92	1.20	0.24	0.72
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	22.43	23.26	12.31	4.92	2.46	0.82	1.92	0.27	0.55	0.55
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	30.32	31.82	11.71	5.40	1.80	2.70	4.50	1.20	1.80	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	21.60	24.96	7.68	5.52	2.40	0.72	1.92	1.20	0.96	0.72
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	21.83	25.92	11.37	7.73	4.32	0.91	1.82	0.91	0.45	0.68
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	18.90	24.55	10.43	5.65	4.78	0.43	3.69	0.87	1.09	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	26.58	33.43	8.42	8.16	3.68	1.58	2.11	1.58	0.53	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	22.04	23.45	8.21	9.62	2.35	2.11	2.35	1.64	0.47	0.70
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	23.85	25.36	12.68	9.66	4.23	1.21	2.42	0.60	1.21	0.60
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	27.31	29.63	11.04	9.30	4.94	1.45	2.03	0.87	0.87	0.58
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	29.04	37.83	11.72	7.99	5.06	1.87	2.93	1.60	1.07	0.53
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	15.76	17.51	11.38	5.25	4.38	2.19	2.19	0.44	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	23.68	22.77	10.47	8.20	5.47	2.28	3.19	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	8.95	17.16	14.92	5.22	8.20	2.98	2.24	2.24	0.00	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	19.45	21.97	6.84	6.48	1.80	1.80	2.16	0.72	0.72	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	16.69	23.02	10.65	6.33	2.01	2.01	1.44	0.00	0.86	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	17.91	25.46	6.36	6.36	1.89	1.65	0.94	2.12	0.24	0.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	23.13	33.27	8.56	7.29	3.80	0.95	3.49	0.63	0.32	0.32
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	22.76	25.84	12.61	8.30	4.92	0.62	2.46	2.46	0.62	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	23.08	29.49	7.69	6.09	3.53	1.28	2.56	1.28	0.32	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	27.16	34.04	8.80	5.74	4.59	1.91	2.68	1.15	0.76	0.76
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	24.04	31.13	7.88	9.06	5.91	0.79	2.36	0.79	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	31.01	27.23	6.81	10.59	6.05	0.76	0.00	1.51	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	52.19	46.57	17.67	6.42	15.26	5.62	2.41	1.61	1.61	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	36.37	38.47	25.18	11.89	13.99	4.20	4.20	2.80	1.40	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	53.09	46.08	18.03	5.01	10.02	4.01	3.01	3.01	3.01	2.00
Cardiac Myocyte, donor1	11525-119I4	18.28	34.73	12.79	3.66	0.00	0.00	1.83	1.83	9.14	0.00
Cardiac Myocyte, donor2	11605-120I3	37.06	20.26	7.41	5.93	3.46	1.48	1.48	1.48	0.99	1.48
Cardiac Myocyte, donor3	11686-122I3	36.09	16.84	10.00	5.26	1.68	0.95	1.26	1.26	0.84	0.63
Chondrocyte - de diff, donor1	11261-116G1	44.72	35.01	21.15	4.16	2.08	0.69	1.39	0.35	1.73	0.00
Chondrocyte - de diff, donor2	11338-117F6	24.52	17.06	7.11	5.33	0.71	0.36	1.78	0.36	0.00	0.36
Chondrocyte - de diff, donor3	11410-118E6	32.43	34.02	21.62	5.69	1.02	0.80	1.93	0.46	1.02	1.37
Chondrocyte - re diff, donor2	11339-117F7	58.19	29.54	19.70	8.95	1.79	2.69	1.79	1.79	1.79	0.00
Chondrocyte - re diff, donor3	11411-118E7	33.97	25.07	12.13	4.85	0.40	1.21	3.24	0.00	0.81	0.81
Ciliary Epithelial Cells, donor1	11242-116D9	64.61	39.59	17.33	12.28	1.84	1.84	2.87	1.49	1.95	1.38
Ciliary Epithelial Cells, donor2	11323-117D9	47.67	27.58	14.96	8.12	1.71	2.14	1.92	2.78	1.07	0.86
Ciliary Epithelial Cells, donor3	11399-118D4	44.96	27.97	15.66	7.79	1.68	1.42	2.65	1.06	1.24	0.71
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	45.02	44.66	22.10	8.53	1.28	3.30	1.65	1.65	1.28	0.28
Corneal Epithelial Cells, donor1	11526-119I5	20.86	6.81	1.54	1.32	0.22	0.22	0.00	0.44	0.00	0.22
Corneal Epithelial Cells, donor2	11606-120I4	19.34	11.38	2.28	1.14	0.00	0.00	1.14	1.14	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	32.72	12.78	3.83	1.53	1.28	0.26	1.28	0.77	0.51	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	41.27	29.06	10.40	4.29	0.50	0.83	0.17	1.49	0.83	0.83
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	40.69	26.18	8.83	5.05	0.95	0.63	0.95	0.63	0.00	0.95
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	31.06	20.70	13.80	0.00	0.00	0.00	0.00	10.35	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	30.35	22.57	12.85	3.89	0.54	0.76	1.08	1.51	0.11	0.65
Dendritic Cells - plasmacytoid, donor1	11228-116C4	49.20	57.05	12.64	8.88	0.00	1.02	2.05	0.34	0.34	0.68
Dendritic Cells - plasmacytoid, donor2	11309-117C4	75.73	65.29	15.02	10.45	1.96	0.00	0.65	0.65	0.65	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	74.04	67.75	18.39	16.94	1.94	4.36	0.48	0.48	0.00	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	22.68	15.51	4.50	3.00	1.67	0.00	1.00	0.17	0.33	0.33
Endothelial Cells - Aortic, donor1	11263-116G3	21.71	11.74	5.28	2.93	0.00	1.17	0.59	0.00	0.00	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	32.80	17.25	5.37	3.11	1.70	0.28	1.98	0.28	0.28	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	20.45	8.26	8.26	3.15	0.79	0.00	0.00	0.79	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	20.36	9.60	4.07	1.75	0.87	0.58	1.16	0.29	0.58	0.29
Endothelial Cells - Artery, donor2	11341-117F9	28.23	15.29	6.59	2.35	2.12	0.24	1.41	0.71	0.24	0.00
Endothelial Cells - Artery, donor3	11413-118E9	20.34	13.50	5.96	3.51	1.23	0.53	1.40	0.53	0.35	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	38.57	24.83	6.65	6.65	0.66	0.22	1.33	1.11	0.44	0.66
Endothelial Cells - Lymphatic, donor2	11317-117D3	45.03	27.08	10.04	5.17	2.43	1.22	2.43	1.22	0.61	1.52
Endothelial Cells - Lymphatic, donor3	11393-118C7	40.59	31.86	9.02	4.79	1.41	1.41	1.41	0.85	0.56	0.85
Endothelial Cells - Microvascular, donor1	11265-116G5	19.91	19.31	3.57	3.27	1.78	1.19	0.89	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	21.87	11.98	2.60	4.17	1.56	0.52	2.60	0.52	0.00	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	14.89	12.62	2.98	2.13	0.71	0.43	0.85	0.14	0.00	0.28
Endothelial Cells - Thoracic, donor1	11266-116G6	41.61	24.81	10.00	5.20	2.40	0.80	3.60	0.80	0.40	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	15.20	5.24	2.62	1.05	2.62	1.57	0.52	0.52	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	66.10	32.43	14.66	10.19	3.23	0.99	3.11	1.49	1.37	0.75
Endothelial Cells - Umbilical vein, donor2	11324-117E1	37.80	15.43	11.08	3.91	0.65	0.43	1.52	1.09	0.43	0.43
Endothelial Cells - Umbilical vein, donor3	11400-118D5	31.14	14.29	9.04	2.56	1.59	0.73	1.47	0.73	0.37	0.24
Endothelial Cells - Vein, donor1	11267-116G7	11.38	12.51	2.28	4.55	1.14	2.28	0.00	1.14	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	18.16	6.99	2.10	2.79	0.70	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	18.84	13.35	8.32	4.71	1.41	0.63	1.88	0.31	0.47	0.31
Eosinophils, donor1	12244-129H3	0.00	30.49	15.25	0.00	0.00	0.00	0.00	0.00	15.25	0.00
Eosinophils, donor2	12245-129H4	33.01	47.86	18.15	3.30	0.00	0.00	0.00	3.30	0.00	1.65
Eosinophils, donor3	12246-129H5	21.40	21.40	14.27	3.57	0.00	0.00	3.57	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	28.83	5.86	1.47	2.44	0.49	0.24	0.00	0.73	0.49	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	22.88	10.40	0.00	2.08	0.00	0.00	0.00	4.16	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	65.08	0.00	0.00	0.00	16.27	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	34.89	26.27	15.60	4.93	0.82	1.64	2.46	1.23	1.64	0.82
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	32.74	11.17	7.77	4.71	1.64	0.66	1.64	1.20	0.44	1.31
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	26.65	6.93	5.74	0.87	0.54	0.11	0.33	0.76	0.33	0.11
Fibroblast - Aortic Adventitial, donor1	11245-116E3	42.81	21.83	12.61	6.31	2.67	2.43	1.94	0.61	1.09	0.61
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	45.44	27.84	12.15	7.23	4.37	0.68	1.77	3.82	0.55	1.64
Fibroblast - Aortic Adventitial, donor2	11326-117E3	30.48	16.56	9.81	3.48	1.27	0.53	1.27	1.05	0.21	0.42
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	55.07	77.73	36.89	20.03	4.74	3.69	6.85	2.63	2.11	1.32
Fibroblast - Aortic Adventitial, donor3	11401-118D6	33.55	22.92	13.29	2.66	1.00	0.66	2.33	0.33	0.00	1.00
Fibroblast - Cardiac, donor1	11268-116G8	43.55	17.24	9.53	3.63	1.36	1.36	0.91	0.91	1.36	0.91
Fibroblast - Cardiac, donor2	11345-117G4	17.43	12.13	4.55	5.31	3.03	0.00	0.00	0.76	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	21.45	12.93	10.41	3.47	2.05	1.10	1.42	0.32	1.10	0.63
Fibroblast - Cardiac, donor4	11452-119A3	32.43	27.28	18.19	6.67	1.21	1.21	1.21	0.61	1.52	0.00
Fibroblast - Cardiac, donor5	11456-119A7	40.99	27.16	17.64	6.09	1.65	2.16	1.65	1.02	1.78	0.51
Fibroblast - Cardiac, donor6	11460-119B2	35.32	23.50	9.25	6.52	1.67	1.21	1.97	1.06	0.61	0.61
Fibroblast - Choroid Plexus, donor1	11492-119E7	46.09	29.21	9.92	8.17	0.94	0.40	0.94	1.34	0.27	0.40
Fibroblast - Choroid Plexus, donor2	11572-120E6	34.51	31.93	19.41	6.90	0.86	1.29	0.43	0.86	0.00	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	54.20	11.72	11.72	5.86	1.46	1.46	1.46	2.93	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	56.51	24.22	6.92	4.38	1.61	0.92	1.61	1.61	0.69	0.69
Fibroblast - Conjunctival, donor3	11692-122I9	43.25	35.28	19.17	4.92	0.85	0.34	0.68	1.02	1.19	0.85
Fibroblast - Dermal, donor1	11269-116G9	33.34	17.14	11.97	3.99	3.05	0.94	1.64	0.94	0.94	0.47
Fibroblast - Dermal, donor2	11346-117G5	34.43	12.74	8.49	2.83	3.30	0.00	0.94	0.00	0.94	0.47
Fibroblast - Dermal, donor3	11418-118F5	30.58	17.65	10.40	4.84	1.69	0.73	1.57	0.73	0.60	0.73
Fibroblast - Dermal, donor4	11450-119A1	40.81	17.64	10.74	5.43	1.02	0.45	2.37	1.81	0.79	1.81
Fibroblast - Dermal, donor5	11454-119A5	44.83	25.82	12.91	6.98	1.92	0.70	1.74	2.97	1.05	0.17
Fibroblast - Dermal, donor6	11458-119A9	41.42	23.06	10.56	7.47	1.14	0.65	0.81	2.11	0.81	0.97
Fibroblast - Gingival, donor1	11237-116D4	57.47	26.03	12.08	5.83	1.46	1.04	1.87	0.83	0.42	1.46
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	42.44	31.44	15.98	4.98	1.05	1.05	1.05	1.83	1.31	0.26
Fibroblast - Gingival, donor2	11318-117D4	45.99	27.28	9.22	8.17	0.79	0.53	1.58	1.32	0.13	1.84
Fibroblast - Gingival, donor3	11394-118C8	44.09	29.49	18.66	4.74	1.26	0.97	1.45	1.06	1.45	0.97
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	43.63	39.48	13.51	9.35	0.00	2.08	0.00	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	29.43	24.49	13.04	4.41	1.59	0.88	1.06	0.53	0.88	0.53
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	42.09	23.54	12.00	4.68	1.56	0.62	1.71	1.09	0.94	2.03
Fibroblast - Gingival, donor6 (control)	11922-125H5	42.33	28.26	12.04	7.17	1.22	1.49	1.35	2.43	0.95	0.81
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	15.17	8.47	5.29	1.06	0.71	0.00	0.71	1.76	1.06	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	43.58	20.04	10.68	4.83	0.73	1.02	0.88	2.05	0.73	0.88
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	47.45	25.77	12.00	6.54	1.91	0.95	1.23	0.95	0.68	0.68
Fibroblast - Gingival, donor8 (control)	11926-125H9	50.79	31.26	13.60	7.24	2.30	0.66	2.52	1.43	0.55	0.99
Fibroblast - Gingival, donor9 (control)	11927-125I1	41.38	43.29	17.90	6.46	0.29	0.73	2.35	1.03	1.91	1.03
Fibroblast - Lung, donor1	11270-116H1	12.23	8.16	1.36	1.36	0.00	0.00	0.00	0.00	1.36	1.36
Fibroblast - Lung, donor2	11347-117G6	38.80	17.91	19.40	11.94	4.48	0.00	1.49	0.00	1.49	2.98
Fibroblast - Lung, donor3	11419-118F6	28.70	16.25	8.02	5.06	1.06	0.21	0.63	0.21	0.42	0.42
Fibroblast - Lymphatic, donor1	11506-119G3	29.99	21.66	4.17	2.50	0.00	0.00	1.67	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	22.38	11.19	8.39	2.80	1.40	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	10.36	5.04	1.96	0.28	0.56	0.00	0.56	0.00	0.28	0.00
Fibroblast - Mammary, donor1	11540-120B1	41.00	23.14	4.87	8.12	0.81	0.00	1.22	0.81	0.00	0.41
Fibroblast - Mammary, donor2	11620-122A9	23.97	7.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	23.83	23.83	17.87	11.91	0.00	0.00	5.96	0.00	5.96	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	45.00	32.01	9.70	8.34	3.10	0.78	1.36	2.52	0.39	0.58
Fibroblast - Periodontal Ligament, donor2	11319-117D5	45.96	18.81	12.59	5.01	1.06	0.46	2.28	3.03	0.61	1.21
Fibroblast - Periodontal Ligament, donor3	11395-118C9	46.51	22.64	10.10	5.81	0.61	0.92	2.75	1.53	0.61	1.84
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	30.15	22.90	14.88	4.58	0.38	1.14	0.76	1.53	0.38	0.76
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	35.37	25.38	14.31	5.94	0.81	0.54	1.89	2.43	1.89	1.08
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	26.21	24.47	14.26	3.13	0.93	0.35	1.28	0.35	1.04	0.58
Fibroblast - Pulmonary Artery, donor1	11250-116E8	42.00	23.88	11.50	5.31	2.65	1.22	2.32	0.99	0.66	0.66
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	33.53	18.90	1.83	5.69	2.24	0.00	0.61	1.83	0.41	0.20
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	22.72	8.69	3.34	1.34	0.00	0.00	1.34	1.34	1.34	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	33.61	18.19	15.42	5.93	1.19	1.19	1.58	0.00	0.00	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	41.08	46.04	19.84	15.48	2.78	2.18	5.95	2.18	1.59	0.99
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	44.58	24.16	10.30	10.30	1.60	0.71	1.78	0.53	1.07	0.53
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	44.74	23.45	11.43	5.32	2.17	0.79	0.79	1.58	0.39	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	58.97	52.65	23.77	18.35	2.71	1.50	3.91	3.61	1.20	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	56.78	32.82	19.86	7.56	2.48	1.30	0.97	0.97	1.08	0.65
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	32.65	46.82	21.01	13.67	0.51	1.52	1.27	3.29	1.77	0.76
Fibroblast - skin normal, donor1	11553-120C5	39.21	31.01	13.78	7.71	2.13	1.31	0.98	0.66	0.49	0.82
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	69.17	68.77	23.66	19.25	2.81	4.01	5.41	2.21	4.01	2.21
Fibroblast - skin normal, donor2	11561-120D4	47.02	35.26	18.28	10.95	2.71	2.71	1.71	1.11	0.70	0.50
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	35.97	49.26	22.67	14.51	1.51	2.42	1.51	3.32	1.21	0.60
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	52.28	33.72	15.24	6.96	1.33	0.75	2.07	1.24	0.83	0.50
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	62.06	38.12	16.75	6.84	1.03	0.68	1.20	2.56	0.51	0.34
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	65.03	59.12	35.80	17.74	4.60	3.28	6.90	3.28	0.99	0.66
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	48.25	36.22	19.07	11.08	3.62	2.98	2.24	2.34	0.96	1.07
Fibroblast - skin walker warburg, donor1	11554-120C6	32.56	19.23	6.07	6.24	2.02	1.01	1.52	1.18	1.01	0.67
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	69.63	47.05	21.33	6.43	2.04	1.25	2.35	1.88	1.41	2.35
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	243.76	88.64	44.32	22.16	22.16	22.16	0.00	22.16	22.16	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	28.76	27.02	21.79	6.10	0.00	1.74	0.00	0.87	1.74	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	35.71	15.43	6.93	7.45	1.56	0.52	2.43	1.56	0.52	0.87
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	47.62	16.92	7.29	9.11	4.68	1.56	1.30	0.52	1.30	0.78
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	38.07	16.10	6.39	5.62	2.30	0.77	1.28	1.79	1.02	1.79
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	71.96	30.62	22.20	6.12	3.83	2.30	0.77	0.77	3.83	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	88.05	46.58	38.28	7.02	8.29	7.66	3.19	1.91	3.19	2.55
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	119.81	55.34	34.52	7.42	2.28	3.42	1.71	5.13	3.14	1.71
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	68.39	45.50	27.02	6.34	1.93	1.93	1.38	4.96	1.10	3.03
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	41.33	32.88	33.34	4.79	4.34	2.74	0.46	3.42	2.51	1.60
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	89.36	35.27	20.80	6.74	1.59	1.59	1.59	3.57	0.99	1.19
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	67.41	34.89	23.53	8.19	1.06	1.59	1.32	5.02	0.79	2.91
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	35.22	32.94	37.83	7.83	6.52	5.87	1.96	1.30	1.63	2.28
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	119.84	40.68	33.17	7.52	3.10	1.77	0.88	3.54	1.33	1.33
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	63.60	40.56	33.92	9.04	3.82	1.41	1.98	1.13	1.70	2.12
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	50.12	28.82	30.79	5.54	2.96	2.96	1.48	1.23	2.83	0.86
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	68.50	32.77	33.85	9.13	2.69	1.61	1.07	2.42	2.95	0.54
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	46.83	20.19	13.75	3.72	2.60	1.24	1.86	2.35	0.62	0.87
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	61.74	21.04	17.16	4.15	2.63	0.83	1.25	2.08	1.52	1.25
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	64.24	27.24	19.92	5.69	2.44	1.63	1.83	2.03	1.22	0.41
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	42.67	21.45	13.23	6.62	1.83	1.60	0.68	1.14	0.46	0.46
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	44.47	20.30	15.82	6.48	3.86	1.25	1.74	1.99	1.00	0.25
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	45.03	21.64	13.99	2.62	3.28	1.97	0.22	1.53	1.09	0.44
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	56.73	26.00	13.30	6.21	2.07	2.07	0.89	0.30	0.89	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	49.12	25.43	17.01	5.40	4.93	0.95	0.32	2.23	2.07	0.16
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	43.79	26.81	20.55	6.26	4.69	1.56	1.12	0.89	1.56	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	38.51	25.20	13.71	4.84	2.02	1.21	1.81	1.81	1.01	1.01
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	54.46	29.86	22.39	5.26	4.41	2.37	2.04	1.36	1.53	0.68
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	61.45	29.53	22.88	8.69	5.59	3.10	2.48	1.15	1.15	0.18
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	52.34	29.86	11.86	7.49	3.12	1.77	0.94	1.56	1.04	0.21
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	50.55	30.40	12.30	5.64	3.24	0.17	1.88	2.56	0.17	0.51
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	46.81	29.21	16.16	5.98	3.54	3.21	2.32	1.88	1.22	0.44
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	55.74	29.12	17.39	7.99	3.58	1.91	1.75	1.91	1.75	0.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	51.66	27.16	19.81	6.94	6.74	3.47	2.65	1.23	1.23	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	53.43	31.56	14.85	8.25	2.27	0.83	2.27	0.83	0.83	0.21
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	46.69	29.98	17.29	4.73	3.00	1.15	1.61	1.84	0.81	0.35
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	42.19	28.52	16.68	7.67	3.67	2.50	2.17	1.67	1.17	0.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	42.54	27.55	14.11	5.73	1.32	0.66	1.10	1.54	0.44	0.22
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	55.35	34.44	17.46	6.27	2.95	1.23	2.09	1.60	2.46	1.23
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	39.23	28.69	14.26	6.32	1.78	2.11	1.46	1.46	1.13	0.65
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	49.71	29.51	14.43	4.81	2.25	0.32	1.92	1.28	1.28	0.96
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	37.43	22.93	15.35	4.17	2.46	1.04	1.61	2.18	1.14	0.38
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	38.59	23.88	11.71	4.59	3.95	1.27	1.90	1.58	0.63	0.63
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	42.88	26.76	12.16	4.87	2.74	0.30	3.04	2.13	0.30	0.91
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	38.78	26.03	16.10	6.06	3.14	1.99	1.78	1.67	1.15	0.73
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	38.20	27.22	14.71	5.05	1.54	0.66	3.51	1.98	1.10	0.66
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	39.00	24.69	12.34	8.70	2.24	0.56	2.52	0.84	1.96	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	28.15	21.02	10.83	6.11	4.07	1.20	1.76	1.67	1.30	0.74
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	37.70	28.88	14.97	6.15	4.28	0.80	2.41	1.60	1.07	0.80
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	36.57	24.02	11.17	8.26	4.59	1.68	1.99	0.77	1.22	0.61
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	26.17	19.56	13.21	5.44	3.76	1.42	2.33	1.94	1.68	0.65
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	40.93	27.11	16.26	9.22	4.07	1.08	3.25	0.81	0.81	0.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	34.66	33.00	18.62	5.90	3.32	1.47	1.84	1.29	1.66	0.37
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	31.80	27.85	16.67	6.80	2.63	0.44	1.97	1.10	1.75	0.66
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	24.79	29.75	14.88	2.98	1.98	0.99	1.98	0.00	0.00	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	31.66	26.78	16.88	5.94	1.71	1.06	1.71	1.06	1.85	0.53
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	31.27	24.82	14.73	6.86	2.62	1.61	1.61	0.81	1.41	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	40.16	25.67	18.30	6.86	1.02	1.02	1.78	1.52	2.80	0.51
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	118.44	67.08	34.64	14.33	3.98	3.78	1.00	1.59	2.59	0.60
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	72.57	36.67	36.52	5.70	2.62	2.77	0.92	1.85	5.24	0.62
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	88.58	53.40	40.71	10.64	4.30	4.09	1.02	2.86	3.07	1.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	68.53	44.44	23.47	11.27	5.63	1.56	1.88	0.63	0.94	1.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	59.34	39.28	20.34	9.89	2.26	2.83	0.57	0.85	2.26	1.13
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	60.42	35.97	33.21	7.38	4.61	4.61	0.00	2.31	0.92	1.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	59.40	29.70	39.60	2.47	2.47	4.95	2.47	0.00	0.00	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	64.98	41.00	34.43	8.51	4.64	1.93	3.09	1.93	3.09	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	78.62	41.72	33.69	11.23	11.23	1.60	0.00	0.00	1.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	46.95	36.52	26.08	5.22	0.00	1.74	0.00	1.74	1.74	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	50.12	33.52	29.29	8.46	3.91	5.86	1.95	1.95	0.98	2.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	68.36	44.47	28.00	10.30	3.71	2.47	2.88	2.06	1.65	1.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	33.32	19.99	33.32	6.66	6.66	0.00	0.00	0.00	3.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	55.93	38.03	26.57	8.39	1.68	3.36	1.96	0.84	1.68	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	56.22	29.74	21.90	7.19	4.25	2.94	1.96	2.29	1.63	1.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	49.49	19.29	16.78	4.19	0.00	4.19	0.00	3.36	0.84	2.52
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	60.75	31.81	21.95	7.63	4.77	2.54	1.59	0.95	1.91	1.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	60.12	32.27	26.15	11.89	4.08	2.72	1.36	1.02	1.70	1.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	56.38	31.32	18.79	6.26	4.18	2.09	4.18	2.09	4.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	71.01	31.50	18.90	10.31	1.72	1.15	2.86	0.57	0.57	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	47.36	24.86	10.06	4.14	0.89	0.89	0.59	0.59	1.18	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	42.35	32.19	35.58	6.78	5.08	5.08	1.69	3.39	1.69	3.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	60.06	44.73	32.72	12.43	4.97	3.73	1.66	1.24	2.07	1.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	54.31	38.89	28.08	10.82	4.14	4.60	1.38	0.23	3.22	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	73.76	31.61	52.68	5.27	0.00	5.27	0.00	5.27	0.00	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	48.82	36.52	22.68	6.54	5.00	1.92	1.15	1.54	2.31	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	48.90	28.03	14.34	8.80	3.91	1.96	1.30	1.30	1.96	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	32.10	23.41	24.75	5.35	2.01	0.67	1.34	0.67	2.68	1.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	78.21	46.23	23.89	5.78	1.54	1.93	2.70	1.93	1.93	2.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	70.86	42.79	27.04	10.95	7.87	4.45	2.05	2.74	1.71	1.37
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	42.24	17.39	9.94	0.00	0.00	0.00	2.48	4.97	2.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	62.76	37.28	11.32	6.61	0.47	0.47	1.42	3.30	0.94	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	58.54	28.97	16.29	7.24	0.60	0.60	1.21	1.81	2.41	1.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	62.57	32.05	22.38	3.05	2.03	1.02	2.54	1.53	0.51	1.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	57.43	40.28	22.73	7.58	0.80	0.80	0.80	1.60	1.20	1.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	80.42	40.46	18.25	10.36	2.47	1.48	2.47	1.97	3.45	0.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	82.63	38.95	22.43	3.54	2.36	0.00	0.00	3.54	1.18	4.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	64.18	40.84	16.34	8.17	3.50	0.58	1.17	1.75	0.58	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	72.42	35.55	14.92	9.66	1.76	0.44	1.32	3.07	1.76	1.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	60.19	23.74	16.11	5.93	3.39	2.54	0.85	1.70	0.85	2.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	44.17	42.38	26.26	4.18	1.79	1.79	1.19	2.98	0.00	1.79
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	41.73	33.97	25.72	6.79	2.91	3.40	1.46	0.97	1.94	0.97
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	18.26	14.84	2.28	3.42	1.14	0.00	1.14	1.14	1.14	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	28.69	14.14	5.82	3.33	0.83	0.83	0.83	0.42	0.42	0.83
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	16.87	11.24	4.50	3.37	1.12	0.00	2.25	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	35.84	21.88	12.37	3.81	2.22	0.00	0.63	0.63	0.32	1.27
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	33.84	14.20	16.29	3.34	1.25	0.84	0.42	1.25	0.84	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	38.06	19.84	10.44	3.48	1.39	2.55	0.70	1.51	1.04	0.81
Hep-2 cells mock treated, biol_rep2	11899-125E9	40.51	18.74	10.63	2.36	2.03	0.84	0.68	1.18	0.51	0.51
Hep-2 cells mock treated, biol_rep3	11900-125F1	31.40	15.47	13.42	2.28	1.59	0.91	1.14	0.68	0.23	1.37
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	38.26	21.32	9.07	3.50	1.53	0.87	0.87	0.87	0.87	0.98
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	33.53	16.33	10.96	2.79	3.01	0.86	0.43	0.86	0.21	0.43
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	31.43	15.50	11.84	1.94	1.94	1.94	0.22	0.43	0.86	0.65
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	44.34	23.04	12.58	3.11	1.87	1.37	0.87	1.12	0.37	0.87
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	40.14	16.30	11.49	2.40	2.23	0.86	0.17	1.03	0.17	0.86
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	33.32	18.26	9.29	2.24	3.20	1.92	0.64	1.28	0.64	0.96
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	30.78	20.15	3.36	4.48	0.56	0.00	1.12	1.68	0.56	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	18.18	9.52	0.87	0.87	0.43	0.00	0.87	0.43	0.43	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	44.94	13.22	0.00	0.00	2.64	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	29.98	12.70	2.47	2.47	0.35	0.00	1.76	1.41	0.00	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	17.44	7.27	5.81	0.73	0.00	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	27.62	15.91	14.51	6.12	2.27	1.75	2.45	0.87	0.52	0.87
Hepatocyte, donor1	11523-119I2	66.58	43.58	47.21	14.53	6.05	2.42	4.84	0.00	3.63	1.21
Hepatocyte, donor2	11603-120I1	63.56	40.94	22.62	17.24	0.00	5.39	3.23	0.00	1.08	1.08
Hepatocyte, donor3	11684-122I1	62.58	51.54	26.38	13.50	2.45	1.84	5.52	3.68	1.23	1.23
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	54.83	26.11	11.75	7.18	0.00	1.31	0.00	0.65	0.65	1.96
Intestinal epithelial cells (polarized), donor1	11246-116E4	51.74	43.17	17.83	13.28	4.37	2.62	2.45	0.70	1.05	1.05
Iris Pigment Epithelial Cells, donor1	11530-119I9	47.75	24.70	10.98	6.31	2.33	0.96	1.65	0.82	0.41	0.41
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	35.02	19.10	6.37	0.00	0.00	0.00	3.18	0.00	3.18	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	26.70	6.68	0.00	6.68	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	24.92	6.92	4.15	1.38	0.00	0.00	1.38	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	27.53	15.02	7.51	5.01	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	47.47	11.87	0.00	11.87	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	20.50	5.13	2.56	5.13	7.69	2.56	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	18.28	4.57	4.57	0.00	9.14	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	32.49	19.49	4.87	0.00	1.62	0.00	1.62	0.00	0.00	3.25
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	35.01	6.67	6.67	3.33	0.00	0.00	1.67	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	25.41	7.26	3.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	30.44	13.23	7.94	9.26	1.32	0.00	2.65	1.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	31.04	5.54	5.54	1.11	1.11	0.00	0.00	0.00	0.00	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	26.19	20.95	5.24	5.24	0.00	0.00	0.00	5.24	0.00	5.24
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	35.27	22.05	4.41	3.78	3.78	1.26	1.89	0.00	0.00	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	29.39	13.92	3.09	0.00	4.64	0.00	3.09	3.09	1.55	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	29.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	32.95	14.21	5.81	3.88	1.29	1.29	2.58	2.58	0.65	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	22.54	11.27	3.22	3.22	4.83	0.00	3.22	1.61	1.61	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	23.90	11.95	0.00	11.95	0.00	0.00	0.00	11.95	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	46.45	11.41	4.89	5.70	3.26	1.63	1.63	0.00	0.81	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	21.83	12.17	3.78	5.88	0.84	2.10	0.42	0.42	0.42	0.84
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	23.31	9.64	5.63	6.43	0.80	1.61	1.61	1.61	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	27.70	12.00	0.92	4.62	3.69	0.00	0.92	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	30.16	0.00	0.00	15.08	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	37.29	17.47	8.50	3.78	2.36	0.47	1.42	1.42	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	27.21	16.33	4.53	1.81	3.63	1.81	0.91	0.91	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	14.74	0.00	14.74	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	23.67	6.46	8.61	2.15	4.30	0.00	0.00	0.00	2.15	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	27.95	7.62	6.35	5.08	2.54	0.00	0.00	0.00	0.00	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	49.29	0.00	0.00	0.00	16.43	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	25.51	12.75	4.46	3.83	1.91	0.00	1.28	1.28	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	18.23	12.76	5.47	3.65	0.00	0.00	1.82	1.82	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	63.22	15.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	32.13	10.71	3.57	5.71	0.00	0.71	0.00	0.71	0.00	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	29.86	3.32	6.64	3.32	0.00	3.32	0.00	0.00	3.32	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	0.00	20.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	27.16	13.58	8.03	5.56	3.70	0.93	1.85	0.31	0.93	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	26.34	7.02	5.27	3.51	1.76	0.00	3.51	0.00	0.00	1.76
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	25.15	12.57	12.57	3.14	0.00	0.00	0.00	6.29	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	25.73	14.60	6.26	6.95	1.39	0.00	0.70	0.70	0.70	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	24.34	6.64	4.43	2.21	0.00	0.00	2.21	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	12.97	9.73	6.48	6.48	3.24	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	15.69	9.59	9.59	0.87	0.87	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	24.75	15.75	6.75	6.75	6.75	0.00	0.00	2.25	2.25	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	13.94	6.97	6.97	0.00	0.00	0.00	3.48	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	20.27	12.80	3.20	3.20	1.07	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	29.09	8.31	9.70	1.39	2.77	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	14.25	8.55	2.85	5.70	0.00	0.00	2.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	19.33	11.05	2.76	0.00	1.84	0.92	0.92	0.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	21.18	27.23	3.03	0.00	0.00	0.00	3.03	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	12.42	12.42	6.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	10.57	9.52	3.17	2.11	0.00	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	38.03	9.87	9.30	6.36	1.88	1.14	1.39	0.41	0.65	0.41
Keratinocyte - epidermal, donor2	11349-117G8	18.74	5.27	4.10	0.59	2.93	0.00	0.59	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	34.64	18.65	12.21	5.21	1.80	0.76	1.33	1.14	1.42	1.51
Keratinocyte - oral, donor1	11251-116E9	99.10	29.63	18.16	9.08	1.59	0.79	2.61	2.72	1.70	1.59
Keratocytes, donor1	11527-119I6	59.83	46.42	8.94	7.91	6.53	1.03	1.03	1.72	1.03	0.34
Keratocytes, donor2	11607-120I5	32.81	10.55	3.52	4.69	1.17	1.17	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	47.03	39.52	20.75	7.51	0.79	0.40	4.15	0.79	0.20	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	30.77	35.17	15.39	4.40	0.00	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	57.17	22.65	11.87	6.47	2.16	0.00	0.00	3.24	0.00	1.08
Lens Epithelial Cells, donor2	11609-120I7	53.98	44.63	15.80	8.65	1.27	1.96	2.19	1.27	1.27	0.35
Lens Epithelial Cells, donor3	11690-122I7	43.29	26.34	13.12	7.57	2.42	1.21	2.02	0.61	0.91	1.41
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	31.90	20.40	6.28	4.74	0.95	0.71	1.78	0.47	0.36	0.24
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	18.42	12.84	5.30	2.51	1.67	0.00	1.67	0.00	0.28	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	38.72	25.50	10.86	7.71	1.42	1.57	0.79	0.63	0.79	0.31
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	24.20	14.52	7.53	4.30	2.15	0.54	0.00	0.54	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	17.33	16.07	2.84	5.67	0.63	0.32	0.00	0.95	0.00	0.63
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	27.17	17.47	3.67	4.64	0.65	0.22	1.40	0.22	0.11	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	28.32	17.65	8.21	3.69	1.23	0.41	0.41	0.41	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	12.14	14.66	4.30	3.03	0.76	0.25	1.77	0.25	0.00	0.51
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	20.97	15.62	6.76	4.93	0.56	0.56	1.27	0.14	0.28	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	22.55	22.15	7.52	2.77	2.77	0.40	0.40	0.00	0.00	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	19.78	15.51	5.43	2.91	1.55	0.19	2.13	0.39	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	15.92	10.18	2.96	1.85	0.74	0.37	0.37	0.19	0.37	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	23.34	14.63	8.01	6.27	0.35	0.70	1.39	0.00	0.70	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	18.13	10.02	3.58	3.82	0.95	0.00	1.43	0.48	0.72	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	18.27	13.73	4.26	5.08	0.82	0.27	1.65	0.41	0.27	0.55
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	22.17	18.79	7.08	3.08	2.46	0.62	0.62	0.00	0.00	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	12.47	11.22	2.81	2.81	0.94	0.94	0.31	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	20.68	18.67	4.94	3.48	0.18	0.00	0.91	0.18	0.00	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	21.72	23.04	8.89	2.30	2.30	0.33	1.32	0.33	0.33	1.32
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	12.30	11.13	3.51	2.93	0.29	0.29	1.76	0.59	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	19.91	13.94	2.24	2.74	0.75	0.25	0.50	0.25	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	25.22	16.97	10.18	3.88	2.42	0.48	1.45	0.00	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	19.12	15.08	4.31	3.50	2.15	0.54	2.15	0.00	0.27	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	24.52	15.29	6.51	4.24	1.21	0.30	0.91	0.00	0.61	0.45
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	21.77	18.66	4.67	5.18	2.07	0.52	0.52	0.00	0.52	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	16.96	16.33	6.70	4.61	1.68	1.05	1.05	0.21	1.05	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	19.55	13.98	5.71	3.31	1.95	0.60	1.20	0.45	0.30	0.45
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	19.95	16.51	6.88	4.82	2.75	0.69	1.38	0.00	0.00	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	16.75	13.55	3.95	3.01	0.94	0.75	0.56	0.00	0.56	0.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	15.80	13.36	3.61	3.39	0.53	0.32	1.06	0.32	0.00	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	22.78	15.51	4.85	4.36	2.91	0.97	0.97	0.48	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	12.24	10.25	2.65	3.64	1.65	0.33	0.66	0.00	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	18.71	12.88	2.23	3.35	0.74	0.50	1.24	0.37	0.25	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	35.54	26.28	10.00	7.03	2.59	1.11	1.48	0.00	0.00	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	14.58	12.35	5.44	3.95	0.99	0.74	1.24	0.00	0.49	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	14.85	11.69	2.89	3.85	0.69	0.27	0.41	0.27	0.27	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	23.16	17.69	7.72	4.82	1.93	0.32	0.64	0.32	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	15.52	17.35	8.83	6.09	1.83	1.22	1.22	0.00	0.30	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	25.61	18.20	7.70	6.02	1.82	0.84	1.26	0.42	0.42	0.84
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	24.53	19.56	7.11	2.49	2.49	1.07	0.71	0.71	0.71	1.42
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	10.67	10.18	3.39	2.42	0.48	0.48	0.00	0.00	0.00	0.97
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	12.45	10.43	2.18	2.49	1.09	0.16	0.16	0.31	0.16	0.47
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	19.70	16.47	4.30	5.01	0.72	0.00	0.36	0.36	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	10.78	12.09	4.90	2.94	0.65	1.63	0.00	0.00	0.65	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	13.65	11.54	2.59	3.30	0.71	0.00	0.24	0.00	0.47	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	30.69	20.17	5.82	4.58	1.73	0.37	0.50	0.62	0.74	0.37
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	8.45	9.22	3.07	1.79	1.02	0.51	0.51	0.00	0.26	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	15.22	12.83	3.28	4.18	1.49	0.30	0.60	0.00	0.00	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	24.93	27.19	4.53	2.27	0.00	0.00	0.00	2.27	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	23.78	16.88	11.51	1.53	0.77	0.00	0.00	0.77	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	17.81	14.84	11.88	0.74	2.23	0.00	0.00	0.74	1.48	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	18.19	14.81	8.89	2.54	0.00	0.42	0.00	0.00	0.42	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	23.21	15.47	7.74	2.11	0.00	0.70	0.70	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	11.21	13.08	2.80	0.00	1.87	0.00	0.00	0.93	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	21.64	12.88	3.09	1.55	0.52	0.52	0.00	1.03	0.00	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	11.89	13.08	4.76	0.00	1.19	0.00	1.19	0.00	1.19	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	23.30	18.55	6.33	2.94	0.68	1.13	0.45	0.23	0.45	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	25.88	17.45	10.76	1.45	0.87	0.29	0.29	0.00	1.16	1.16
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	26.56	29.26	11.70	2.70	0.45	1.35	0.45	0.90	0.45	1.35
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	26.69	22.90	7.18	3.66	1.35	1.08	0.68	0.54	0.68	0.41
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	19.51	17.97	5.14	1.03	1.03	1.54	0.51	1.54	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	29.29	22.94	9.17	3.53	1.06	0.71	0.71	1.06	0.71	0.71
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	27.98	17.32	10.66	1.33	0.00	0.67	0.00	0.67	1.33	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	26.49	15.79	7.13	4.58	0.51	0.51	0.51	0.51	1.53	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	29.62	22.95	9.07	4.80	0.53	1.60	0.80	0.80	0.80	0.80
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	32.50	22.86	9.64	3.78	0.94	1.70	0.76	0.38	1.32	0.57
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	20.86	22.09	12.27	3.07	0.00	1.23	0.00	0.00	0.00	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	23.65	22.02	4.08	2.45	2.45	0.00	1.63	0.00	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	28.74	22.49	7.29	4.16	0.62	1.04	1.04	1.25	0.83	1.46
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	24.10	20.74	10.93	6.73	0.56	0.28	1.12	0.56	1.96	1.40
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	25.76	21.64	6.18	5.15	1.03	3.09	1.03	0.00	4.12	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	28.74	22.35	11.32	3.48	0.87	2.03	0.87	0.58	0.29	1.45
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	26.01	21.82	11.66	2.69	0.90	0.60	0.30	0.60	1.20	0.90
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	19.92	16.60	8.30	3.32	0.00	2.21	0.00	1.11	0.00	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	24.04	20.50	9.19	4.95	0.00	0.71	0.35	0.71	0.71	1.77
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	19.55	18.81	9.96	5.16	0.37	1.11	1.11	0.00	0.74	1.11
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	20.72	20.72	0.00	3.45	0.00	1.15	0.00	1.15	0.00	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	23.41	18.04	6.91	2.30	0.38	0.77	0.00	1.54	0.77	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	18.12	15.85	7.36	2.26	0.57	1.13	0.57	1.70	1.70	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	22.97	22.97	6.56	2.46	0.82	0.82	0.82	0.00	0.82	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	25.31	14.91	7.23	2.71	0.90	0.45	0.45	0.45	1.36	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	25.14	18.67	10.77	1.44	0.00	0.00	0.00	0.00	0.72	1.44
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	27.64	26.89	6.72	1.49	1.49	1.49	2.24	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	27.87	16.35	7.80	2.60	1.11	0.00	0.00	0.37	0.74	0.74
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	20.25	18.09	9.05	3.02	0.43	0.00	0.43	0.43	1.29	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	18.84	16.27	11.13	2.57	0.00	0.00	0.86	0.00	0.00	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	19.99	21.32	9.66	1.33	0.00	1.33	0.67	1.00	0.67	1.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	24.13	19.31	6.03	4.83	0.60	1.21	0.60	0.00	0.00	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	15.64	24.17	2.84	3.55	0.71	0.71	2.13	0.71	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	24.40	16.84	4.12	2.41	0.34	1.03	2.41	0.00	0.00	1.03
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	20.93	25.76	5.37	3.76	0.00	0.54	0.00	0.00	0.00	1.07
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	18.18	11.45	7.41	3.37	0.00	0.67	1.35	1.35	0.67	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	21.48	16.30	9.63	1.11	0.00	1.11	0.37	0.74	0.74	1.11
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	30.24	23.26	5.81	3.49	0.00	0.00	1.16	0.00	1.16	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	15.87	20.10	6.35	0.00	0.00	1.06	1.06	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	26.01	17.61	6.40	3.60	0.80	0.40	0.00	0.40	0.80	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	18.17	8.00	10.18	1.45	0.00	0.73	0.00	0.73	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	20.70	26.06	6.90	2.30	0.00	0.77	0.00	0.00	0.77	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	28.12	19.73	5.92	1.97	0.49	0.99	0.49	0.00	0.99	1.97
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	20.70	9.41	8.47	0.94	0.00	1.88	0.00	0.00	0.94	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	17.10	16.59	6.03	2.01	0.50	1.01	0.50	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	15.77	12.62	9.46	3.15	0.00	0.90	0.45	1.35	0.45	1.80
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	15.49	15.49	10.33	1.72	0.00	1.72	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	22.27	20.04	9.35	3.56	0.00	0.00	0.45	0.00	0.89	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	21.12	21.90	5.87	2.74	0.78	1.56	0.00	1.96	1.17	0.78
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	25.07	20.45	8.58	1.98	0.66	0.00	2.64	1.32	0.66	1.98
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	28.02	19.20	9.86	1.56	0.52	0.52	0.52	1.04	0.52	1.04
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	26.69	17.94	12.25	3.94	1.75	1.75	0.44	0.88	0.44	1.31
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	27.96	11.74	10.06	0.56	0.56	0.00	0.00	1.12	1.12	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	15.90	16.34	8.39	2.21	0.44	0.44	0.88	0.44	0.00	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	23.91	19.67	12.73	3.47	0.00	0.77	0.39	1.16	0.77	0.77
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	26.84	20.25	7.60	5.57	0.00	1.52	1.01	0.00	2.03	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	24.51	22.59	12.50	2.88	1.44	0.96	0.00	0.96	0.48	0.48
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	22.66	21.87	8.35	5.57	1.19	1.59	0.40	0.00	1.19	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	27.34	18.84	9.72	1.82	1.22	1.22	1.22	0.61	1.22	1.22
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	17.98	18.68	7.61	3.46	1.38	0.69	0.00	1.38	0.00	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	25.08	21.28	10.26	3.42	0.38	0.38	0.76	0.00	0.76	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	29.95	23.24	8.78	0.52	0.52	1.55	1.03	1.55	1.03	1.55
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	22.98	13.30	12.70	3.63	0.60	1.81	0.60	0.60	0.60	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	23.13	22.18	7.92	2.22	0.63	0.95	0.32	0.63	0.32	0.63
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	22.92	11.19	11.19	1.60	1.60	0.53	0.00	0.00	0.53	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	24.14	22.99	12.64	1.15	1.15	0.00	0.57	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	20.06	24.17	7.20	3.60	1.03	1.54	0.00	0.00	0.51	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	39.61	21.22	8.49	7.07	1.41	0.71	0.71	2.12	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	22.70	27.81	10.78	1.13	0.00	0.00	0.57	1.13	0.57	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	28.29	21.63	9.57	3.33	0.00	0.83	0.00	0.83	0.00	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	33.67	18.01	12.53	3.92	0.00	0.00	0.00	0.00	0.00	1.57
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	23.80	27.14	9.60	5.01	0.84	2.92	0.00	0.42	0.84	0.84
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	30.67	19.51	9.76	1.86	0.46	0.46	0.46	1.39	0.46	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	20.74	19.40	7.36	3.35	2.01	0.67	0.00	0.67	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	17.64	19.78	9.62	4.81	1.07	1.60	0.00	2.14	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	31.92	25.05	9.70	0.81	0.00	1.62	0.81	0.81	0.40	1.62
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	19.27	11.01	10.10	4.59	0.00	0.00	0.00	0.92	1.84	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	22.23	21.34	6.22	3.56	0.00	1.78	0.00	1.78	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	18.81	21.66	10.83	3.99	1.14	0.00	0.57	0.00	0.57	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	24.54	17.64	6.14	1.53	1.53	0.00	0.00	0.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	21.34	19.70	7.11	4.92	1.64	0.55	0.00	1.09	0.55	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	21.83	13.36	6.24	3.12	1.34	1.78	0.45	0.45	0.89	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	17.42	16.12	7.80	3.90	0.52	1.04	1.04	0.52	0.78	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	15.25	14.59	5.97	4.64	0.00	0.66	0.66	1.33	0.00	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	18.71	20.79	2.08	2.08	0.00	0.00	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	41.25	29.40	11.62	7.75	0.23	0.23	0.00	1.37	0.46	1.14
Macrophage - monocyte derived, donor2	11313-117C8	42.57	24.04	8.99	5.32	0.37	0.18	0.18	1.84	1.47	0.73
Macrophage - monocyte derived, donor3	11389-118C3	36.31	20.19	10.88	5.24	0.26	0.39	1.57	1.44	0.79	0.66
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	47.79	18.59	9.56	9.03	4.25	1.59	1.59	2.12	0.53	1.06
Mallassez-derived cells, donor2	11929-125I3	61.00	24.56	15.05	7.29	5.70	4.44	1.74	1.43	1.11	1.58
Mallassez-derived cells, donor3	11930-125I4	63.93	18.35	8.34	7.92	7.51	4.17	1.67	1.11	1.11	1.95
Mammary Epithelial Cell, donor1	11273-116H4	61.88	39.56	27.70	9.86	5.28	4.58	4.09	0.90	3.29	1.59
Mammary Epithelial Cell, donor2	11350-117G9	63.41	19.98	22.01	6.66	4.92	5.50	3.76	1.16	1.74	0.58
Mammary Epithelial Cell, donor3	11422-118F9	17.96	12.22	4.99	2.24	0.50	0.50	0.00	0.00	0.25	0.00
Mast cell - stimulated, donor1	11487-119E2	55.59	55.59	48.81	8.14	6.10	9.49	3.39	0.00	2.71	1.36
Mast cell, donor1	11563-120D6	37.85	60.45	20.87	10.17	0.32	1.51	1.73	0.22	0.76	0.43
Mast cell, donor2	11565-120D8	40.71	50.82	23.77	10.70	0.30	0.30	2.38	1.49	1.19	0.59
Mast cell, donor3	11566-120D9	42.32	63.49	29.49	7.65	0.90	0.68	2.48	0.90	0.45	1.35
Mast cell, donor4	11567-120E1	41.13	60.10	25.71	8.16	0.35	0.18	1.42	0.53	0.71	0.89
Mast cell, expanded and stimulated, donor5	11940-126A5	55.11	86.05	25.06	16.86	0.44	0.44	1.55	1.55	0.67	0.44
Mast cell, expanded and stimulated, donor8	11942-126A7	35.02	39.11	25.10	11.67	0.58	1.75	2.92	2.33	1.75	0.00
Mast cell, expanded, donor5	11939-126A4	39.12	63.44	16.41	11.59	0.46	0.46	2.18	0.92	0.92	0.80
Mast cell, expanded, donor8	11941-126A6	36.49	52.39	26.95	8.87	0.50	0.33	0.84	1.51	1.17	0.33
Melanocyte - dark, donor1	11502-119F8	58.21	35.72	11.04	8.46	0.90	1.79	1.79	0.50	0.80	0.90
Melanocyte - dark, donor2	11582-120F7	41.88	33.57	10.38	10.38	3.11	0.35	3.81	1.38	1.04	0.00
Melanocyte - dark, donor3	11663-122F7	47.30	31.08	12.60	8.55	1.81	1.16	1.67	1.01	1.38	1.09
Melanocyte - light, donor1	11274-116H5	11.99	6.82	2.35	1.88	1.41	0.47	1.18	0.24	0.47	0.24
Melanocyte - light, donor2	11351-117H1	20.47	6.82	0.68	0.00	0.00	0.00	0.00	0.68	0.68	0.00
Melanocyte - light, donor3	11423-118G1	11.27	8.67	2.60	1.73	0.87	0.00	1.73	0.00	0.87	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	39.98	20.20	8.95	5.31	1.87	0.42	1.04	1.77	0.94	0.94
Melanocyte, donor2 (MC+2)	12739-135I3	39.00	31.20	17.75	8.88	5.11	2.15	1.61	1.61	1.34	1.08
Melanocyte, donor3 (MC+3)	12837-137B2	34.82	30.00	11.52	5.62	1.87	1.61	1.07	0.80	1.87	1.87
Meningeal Cells, donor1	11493-119E8	40.32	25.93	7.07	7.07	2.61	0.25	0.99	1.24	0.62	0.12
Meningeal Cells, donor2	11573-120E7	39.61	24.21	10.12	6.16	0.88	0.44	2.64	3.08	0.44	0.00
Meningeal Cells, donor3	11654-122E7	53.30	25.35	11.57	9.37	1.71	0.98	1.96	0.98	0.90	0.73
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	43.06	27.66	12.55	8.84	0.86	2.00	2.57	0.86	0.86	1.14
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	43.17	25.46	10.67	8.65	2.21	0.91	1.71	0.70	0.40	1.01
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	5.26	6.57	2.63	2.63	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	15.70	3.92	2.62	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	38.03	17.22	6.46	3.59	1.44	0.00	2.15	0.72	0.72	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	32.61	22.66	11.01	6.78	3.18	2.33	1.91	1.27	1.06	0.42
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	24.13	24.63	15.08	4.02	1.51	1.01	3.52	1.51	0.50	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	29.45	12.97	3.74	2.64	0.88	0.00	1.10	0.66	0.66	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	26.30	10.96	5.84	2.19	1.46	0.00	0.73	1.46	0.73	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	19.44	9.00	2.86	2.46	1.23	0.20	0.00	0.41	0.61	0.41
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	51.80	32.13	17.31	10.39	0.97	0.55	1.66	1.39	1.25	0.83
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	19.70	15.24	1.86	1.49	1.49	0.00	0.00	0.37	0.74	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	60.13	33.81	15.26	9.21	1.84	0.79	2.63	1.05	1.18	1.45
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	24.04	14.84	2.97	2.37	0.59	0.30	0.30	0.59	0.89	0.89
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	18.68	14.01	2.34	2.34	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	23.05	11.53	6.40	3.84	0.64	0.64	0.00	1.28	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	38.99	26.94	6.73	9.92	3.19	1.77	1.42	1.77	1.42	0.71
Mesenchymal stem cells - hepatic, donor0	11218-116B3	51.91	37.21	14.07	5.94	2.19	1.25	2.50	1.56	0.63	0.63
Mesenchymal stem cells - umbilical, donor0	11214-116A8	32.66	20.32	20.32	3.63	0.73	0.73	1.45	0.73	2.18	2.90
Mesothelial Cells, donor1	11247-116E5	60.19	33.15	9.55	7.16	5.04	2.39	1.06	1.59	0.53	1.86
Mesothelial Cells, donor2	12156-128G5	54.05	19.52	11.01	8.51	2.00	2.50	3.00	0.50	1.50	0.00
Mesothelial Cells, donor3	11402-118D7	39.75	18.93	15.46	6.21	2.53	1.01	2.89	1.08	0.65	0.72
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	21.61	8.10	20.25	6.75	0.00	1.35	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	39.90	27.09	13.79	5.17	0.49	0.99	0.99	2.22	0.25	1.48
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	35.04	21.20	7.36	4.42	0.00	0.00	0.88	1.18	0.00	0.59
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	13.83	0.00	17.29	0.00	0.00	0.00	0.00	0.00	3.46	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	32.54	20.15	11.16	4.34	0.00	0.00	0.93	1.24	0.62	0.62
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	24.68	14.11	4.36	3.73	0.41	0.21	1.24	1.04	0.21	0.83
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	9.26	11.58	16.21	0.00	0.00	0.00	0.00	0.00	2.32	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	35.29	27.28	11.01	6.26	0.75	0.50	1.75	1.00	0.50	1.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	29.33	17.22	4.19	6.05	0.00	0.00	0.93	0.47	0.47	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	38.93	0.00	77.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	33.12	22.15	8.74	4.67	0.61	0.20	0.41	2.44	1.02	0.41
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	24.55	15.84	3.17	3.96	0.40	0.40	0.40	0.40	0.40	0.79
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	8.55	25.65	8.55	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	34.51	17.70	9.73	7.08	0.00	0.88	0.00	0.00	0.88	1.77
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	28.50	22.80	5.70	4.94	0.76	0.38	0.00	0.76	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	7.90	2.63	11.84	0.00	0.00	0.00	0.00	2.63	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	25.25	17.61	7.22	4.67	0.21	0.21	0.21	0.42	0.64	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	12.89	7.37	4.60	0.92	0.00	0.92	0.00	2.76	1.84	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	25.63	18.48	7.45	3.58	0.30	0.89	0.30	1.19	0.89	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	10.06	3.35	10.06	0.00	0.00	1.68	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	33.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	26.85	15.05	10.04	3.26	0.75	0.50	1.51	1.51	0.50	1.51
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	26.14	14.50	6.42	3.57	0.48	0.24	0.24	0.48	0.24	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	12.16	3.87	6.08	1.66	0.00	0.55	0.00	0.00	0.00	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	28.32	15.20	6.22	3.68	0.23	0.23	0.46	0.92	0.23	0.69
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	22.30	14.09	6.31	2.52	0.21	0.21	1.05	1.26	0.21	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	20.18	13.86	6.52	1.43	0.20	0.41	0.82	1.02	0.00	1.22
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	23.60	19.09	7.08	3.43	1.07	0.43	1.07	0.86	0.00	1.07
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	18.45	11.34	6.45	1.56	0.00	0.67	0.22	0.89	0.44	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	51.59	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	18.62	13.14	6.57	3.29	0.44	0.44	0.44	0.66	0.44	0.66
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	12.67	7.10	4.06	2.03	0.00	0.00	0.51	0.00	0.51	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	11.60	4.97	9.94	3.31	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	18.21	10.60	6.25	2.45	0.54	0.82	0.54	0.82	0.27	1.09
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	18.53	12.94	4.12	3.53	0.59	0.29	0.00	1.47	0.00	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	8.72	7.63	13.08	2.18	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	24.51	12.97	5.77	1.92	0.48	0.00	0.48	0.00	0.96	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	19.61	14.01	3.60	2.40	0.80	0.00	1.20	0.40	0.40	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	15.08	9.60	9.60	1.37	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	23.53	11.01	6.01	1.50	0.50	0.00	0.50	0.00	0.00	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	26.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	4.08	6.12	12.23	2.04	0.00	0.00	0.00	0.00	4.08	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	17.95	12.70	4.82	1.75	0.44	0.44	1.31	0.88	0.00	0.88
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	12.14	4.41	6.62	1.10	0.00	0.00	0.00	0.00	2.21	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	10.25	5.76	12.81	0.00	0.64	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	21.82	8.93	7.44	5.45	0.99	0.74	0.25	0.50	0.00	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	10.44	4.18	2.78	2.09	0.70	0.70	0.00	0.70	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	17.68	13.26	6.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	25.30	14.70	6.84	3.42	1.37	0.34	1.03	0.68	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	14.00	4.81	3.94	1.75	0.44	0.00	0.00	1.31	0.44	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	11.72	6.04	7.81	1.42	0.36	1.42	0.00	0.36	0.36	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	18.52	17.39	5.89	5.89	0.84	0.28	0.28	2.24	0.56	1.40
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	19.12	6.65	3.33	4.16	0.42	0.83	1.25	2.08	0.00	0.83
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	11.65	5.83	12.24	0.58	0.00	0.58	0.00	1.17	1.17	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	18.40	15.69	6.03	3.32	0.30	0.30	0.90	1.51	0.30	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	22.12	10.43	5.01	2.50	0.83	0.42	0.42	1.25	0.42	0.83
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	7.22	0.00	7.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	24.01	15.70	8.31	0.92	0.00	0.00	0.92	0.00	0.00	1.85
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	24.47	10.81	9.11	3.41	0.57	1.14	0.00	1.71	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	16.86	14.23	8.43	3.04	0.55	1.38	0.55	0.83	0.83	0.41
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	24.88	19.18	7.77	3.63	0.52	0.78	0.52	0.78	0.78	1.04
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	21.45	14.16	9.01	3.00	0.00	0.86	0.86	2.57	0.86	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	10.80	10.80	8.26	0.64	0.00	1.91	0.00	0.00	0.00	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	22.42	12.28	8.27	3.74	0.27	0.53	0.80	1.07	1.07	0.80
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	29.93	20.06	10.48	6.88	1.80	0.30	0.30	2.69	0.30	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	16.10	11.44	9.75	2.40	0.57	0.57	1.27	0.57	0.42	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	26.44	21.02	8.60	4.14	0.32	0.00	0.64	1.27	0.64	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	24.55	20.34	9.51	6.19	0.88	1.55	0.66	1.99	1.11	0.66
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	18.58	14.79	13.27	3.41	0.00	0.76	0.38	0.00	0.38	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	33.24	19.60	10.23	4.55	0.57	0.57	1.70	1.14	0.57	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	26.06	27.04	7.62	5.65	1.47	1.23	0.98	0.98	0.98	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	18.90	7.82	21.51	3.91	0.65	0.00	0.65	0.65	1.96	1.30
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	27.64	19.41	10.58	4.41	0.29	0.29	1.47	1.47	0.88	0.59
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	46.71	27.39	14.42	8.65	0.86	0.86	1.73	2.02	1.73	0.86
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	40.80	18.55	18.13	6.59	1.65	0.82	1.24	0.00	0.00	0.82
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	22.04	19.65	14.00	5.96	0.00	1.19	0.60	1.19	0.60	0.60
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	48.97	22.60	18.83	0.00	0.00	0.00	3.77	0.00	3.77	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	30.30	8.91	7.13	7.13	0.00	0.00	1.78	1.78	1.78	1.78
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	38.44	25.96	11.83	6.24	0.33	0.00	0.99	2.63	0.66	0.66
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	25.25	14.73	8.42	2.10	1.05	0.00	0.00	1.05	1.05	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	40.13	27.48	9.29	5.54	0.20	0.00	0.59	1.19	0.20	0.40
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	24.21	18.63	12.11	0.93	0.00	0.00	0.93	1.86	0.00	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	28.54	19.53	11.64	1.50	0.00	0.00	0.38	1.13	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	33.29	20.51	7.72	3.73	0.27	0.27	0.80	0.80	0.53	0.53
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	42.98	25.56	8.37	5.54	0.57	0.45	0.57	0.57	0.57	0.57
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	23.58	11.05	10.31	3.68	0.00	0.00	0.00	0.74	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	22.72	16.49	10.63	4.40	0.37	1.10	0.37	0.00	2.93	0.73
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	32.67	15.56	6.22	1.56	1.56	0.00	0.00	0.00	0.00	4.67
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	64.13	43.29	16.57	3.74	1.60	1.07	1.60	2.14	1.07	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	42.50	3.86	27.05	0.00	0.00	0.00	0.00	3.86	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	27.27	14.14	6.06	3.03	2.02	0.00	0.00	1.01	1.01	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	36.26	26.56	8.85	4.22	0.84	0.42	0.42	0.42	0.42	0.84
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	83.08	36.77	17.71	8.17	1.36	4.09	4.09	2.72	1.36	1.36
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	72.48	50.86	29.25	9.54	1.91	1.27	0.64	3.18	0.00	1.27
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	85.03	59.12	40.49	7.29	0.81	4.05	1.62	2.43	3.24	2.43
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	37.76	21.15	10.57	10.57	0.00	1.51	0.00	3.02	0.00	1.51
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	28.55	11.42	0.00	5.71	0.00	5.71	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	48.94	32.62	0.00	3.26	3.26	3.26	0.00	3.26	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	28.51	23.76	9.50	9.50	4.75	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	12.55	12.55	0.00	0.00	0.00	12.55	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	54.07	22.41	14.87	5.82	4.31	1.51	1.72	1.29	1.94	0.65
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	32.92	17.77	20.90	3.14	1.05	0.52	1.05	1.57	1.05	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	24.03	14.02	4.67	8.01	1.33	0.00	1.33	2.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	22.12	9.60	5.84	0.42	0.42	0.83	0.83	0.83	0.42	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	95.45	45.82	18.82	6.85	1.52	1.90	2.66	3.80	1.14	1.33
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	62.24	23.94	30.32	4.79	1.60	0.00	0.00	0.00	1.60	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	24.48	11.56	5.44	2.04	0.00	0.00	1.36	0.00	0.00	1.36
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	145.17	101.07	33.08	12.86	0.00	0.00	3.68	9.19	5.51	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	25.53	10.88	7.95	2.51	0.42	0.00	1.67	2.09	0.00	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	41.37	19.06	8.37	2.09	2.09	0.23	0.93	0.70	0.23	1.16
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	33.78	11.89	5.13	1.35	0.54	0.54	0.27	0.81	0.00	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	37.21	15.98	10.09	3.99	0.84	0.63	0.84	1.26	0.42	0.42
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	100.21	100.21	33.40	11.13	11.13	0.00	0.00	11.13	11.13	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	34.74	17.87	7.94	6.45	1.49	0.00	0.99	1.49	0.50	0.99
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	60.63	34.10	18.95	4.33	0.54	0.27	1.35	2.44	0.54	0.81
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	32.19	11.33	7.25	2.27	0.23	0.23	1.13	0.91	0.00	1.59
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	28.41	16.17	6.37	2.29	0.00	0.98	1.31	0.49	0.00	0.65
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	49.03	23.33	14.94	4.56	1.28	0.91	1.28	1.64	0.73	0.73
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	27.05	14.32	5.83	6.37	0.00	0.00	1.59	2.12	0.53	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	23.41	6.00	8.40	3.60	0.00	0.60	0.60	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	146.70	65.96	24.94	7.55	2.30	1.97	1.31	5.58	0.66	1.97
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	29.60	10.25	5.53	1.46	1.14	0.00	1.14	0.49	0.16	0.81
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	42.68	20.81	16.40	4.59	0.88	1.06	0.71	1.23	1.06	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	33.76	16.17	10.55	2.11	0.70	0.00	1.41	0.00	0.00	1.41
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	36.32	15.17	10.57	4.14	0.46	1.38	0.92	4.14	0.00	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	30.85	12.21	9.00	1.93	0.64	0.32	1.29	0.96	1.61	1.29
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	150.72	62.08	26.56	6.55	1.38	1.38	3.45	5.86	1.03	6.55
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	182.05	101.14	50.57	15.17	7.59	2.53	2.53	2.53	7.59	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	29.85	16.71	13.14	3.56	1.78	0.45	1.78	0.89	0.89	0.45
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	43.19	17.36	6.35	3.81	1.69	0.42	1.69	0.85	0.42	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	63.37	29.19	14.95	3.32	0.71	0.95	0.95	2.85	0.24	0.71
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	36.06	13.74	8.58	0.43	0.00	0.00	0.86	1.72	1.29	0.86
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	162.50	135.42	18.06	36.11	9.03	27.08	0.00	0.00	9.03	18.06
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	22.99	15.33	8.00	4.00	0.33	0.67	1.00	0.00	0.33	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	33.36	11.27	13.53	2.71	1.35	0.90	0.45	0.45	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	25.79	15.48	7.54	2.38	1.19	0.00	1.59	2.38	1.19	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	31.57	11.14	3.71	1.86	0.00	0.00	1.86	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	44.27	20.05	18.92	4.92	1.51	1.14	1.51	1.51	0.76	2.65
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	22.81	15.32	7.50	2.61	0.98	0.33	0.33	2.93	0.98	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	17.00	13.51	5.23	1.74	0.00	0.44	0.44	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	38.44	20.35	20.35	4.52	3.17	1.81	0.90	0.90	1.36	2.71
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	29.98	11.46	3.53	3.53	0.00	0.00	2.65	0.88	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	35.90	19.28	5.32	2.66	2.66	0.00	0.00	1.33	0.00	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	24.80	12.90	6.45	3.47	1.49	0.00	0.50	0.99	0.99	0.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	27.18	8.80	9.95	1.53	1.53	0.38	1.53	0.77	0.00	0.77
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	39.92	37.81	18.15	4.23	1.21	0.00	1.51	2.12	1.21	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	34.26	16.58	11.71	2.65	1.77	0.66	0.66	1.33	1.33	0.66
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	25.75	12.20	10.16	2.71	4.07	0.00	2.03	0.00	0.68	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	91.97	122.63	51.10	0.00	0.00	5.11	0.00	10.22	0.00	5.11
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	26.83	12.19	7.93	1.83	0.61	0.00	0.61	0.61	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	23.61	12.27	8.50	1.89	0.00	0.94	0.31	0.94	0.31	0.94
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	29.05	13.32	9.38	2.42	0.61	0.30	0.61	0.61	0.00	0.61
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	29.27	12.66	4.75	0.79	0.79	0.00	0.00	0.00	0.00	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	151.91	90.69	39.68	7.94	0.00	1.13	0.00	6.80	2.27	3.40
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	177.03	116.33	60.69	10.12	0.00	5.06	10.12	10.12	0.00	5.06
Myoblast, donor1	11241-116D8	41.24	16.27	16.65	4.72	3.11	2.61	1.61	1.49	1.99	1.99
Myoblast, donor2	11322-117D8	44.11	20.52	12.66	6.33	0.96	0.38	2.30	1.92	1.34	2.30
Myoblast, donor3	11398-118D3	44.39	25.22	16.98	8.91	3.03	4.04	2.69	1.35	1.35	0.34
NK T cell leukemia cell line:KHYG-1	10777-110G3	40.72	33.86	10.07	7.73	0.88	2.77	2.63	0.58	1.17	0.88
Natural Killer Cells, donor1	11230-116C6	30.75	35.67	17.22	9.53	3.69	9.53	2.46	0.31	2.46	0.31
Natural Killer Cells, donor2	11311-117C6	22.01	28.65	17.79	6.63	2.71	6.63	4.82	0.00	1.51	0.60
Natural Killer Cells, donor3	11387-118C1	28.53	25.77	20.80	8.65	2.02	4.79	4.05	0.37	2.02	0.00
Neural stem cells, donor1	11275-116H6	71.86	66.78	29.04	19.60	4.36	4.72	3.27	1.45	2.90	1.45
Neural stem cells, donor2	11352-117H2	67.40	51.99	30.81	7.70	7.70	5.78	5.78	5.78	5.78	0.00
Neurons, donor1	11494-119E9	75.10	53.48	20.48	18.21	9.10	7.97	0.00	1.14	3.41	1.14
Neurons, donor2	11574-120E8	73.75	61.65	26.64	12.11	2.42	3.08	2.86	1.98	1.54	0.66
Neurons, donor3	11655-122E8	72.35	73.17	22.20	13.98	4.93	3.29	1.64	6.58	2.47	2.47
Neutrophils, donor1	11233-116C9	37.12	47.33	11.14	4.64	0.00	1.86	0.93	0.93	0.00	0.93
Neutrophils, donor2	11314-117C9	31.89	34.79	5.80	2.90	0.00	0.00	2.90	0.00	0.00	5.80
Neutrophils, donor3	11390-118C4	60.47	28.10	5.50	4.28	0.00	1.83	1.22	1.22	1.22	1.83
Nucleus Pulposus Cell, donor1	11252-116F1	59.49	45.71	23.63	9.38	0.59	1.54	2.26	1.07	3.21	0.95
Nucleus Pulposus Cell, donor2	11409-118E5	34.84	23.44	15.63	6.19	0.00	0.65	0.98	0.98	0.65	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	40.31	26.67	21.26	8.22	0.60	1.20	1.80	1.00	2.61	0.60
Olfactory epithelial cells, donor1	11933-125I7	26.02	16.11	10.60	3.17	0.55	0.55	1.24	1.38	0.83	0.41
Olfactory epithelial cells, donor2	11934-125I8	44.29	21.71	18.53	4.34	1.16	0.43	1.59	1.01	0.72	1.88
Olfactory epithelial cells, donor3	11935-125I9	35.53	21.11	16.12	4.65	1.14	0.68	0.91	0.79	1.02	1.36
Olfactory epithelial cells, donor4	11936-126A1	33.80	24.15	14.22	4.29	0.78	0.68	1.07	0.88	0.68	0.97
Oligodendrocyte - precursors, donor1	11496-119F2	68.01	29.49	12.64	1.81	1.81	3.01	3.01	0.60	0.60	2.41
Osteoblast - differentiated, donor1	11276-116H7	28.29	17.44	8.08	3.62	0.21	0.64	0.64	0.43	0.43	0.00
Osteoblast - differentiated, donor2	11353-117H3	11.43	13.72	4.57	1.14	0.00	0.00	1.14	1.14	0.00	2.29
Osteoblast - differentiated, donor3	11425-118G3	11.17	13.03	11.17	2.48	1.24	1.24	0.00	0.00	0.00	0.62
Osteoblast, donor1	11277-116H8	24.43	16.61	5.08	5.08	1.56	0.39	1.17	0.39	0.20	0.59
Osteoblast, donor2	11354-117H4	38.63	28.09	19.66	4.92	2.11	2.11	4.21	4.21	1.40	0.00
Osteoblast, donor3	11426-118G4	20.79	14.93	6.40	4.27	0.18	0.53	0.89	0.18	2.13	0.18
Pancreatic stromal cells, donor1	11249-116E7	44.56	29.23	12.80	7.16	1.77	1.26	2.27	1.52	1.10	1.10
Pericytes, donor1	11491-119E6	19.47	14.91	2.89	2.67	0.33	0.11	0.00	0.11	0.11	0.11
Pericytes, donor2	11571-120E5	19.92	22.18	3.85	3.17	0.68	0.23	0.91	0.91	0.45	0.00
Pericytes, donor3	11652-122E5	21.36	9.77	5.90	1.63	1.02	0.61	0.81	0.41	0.81	0.20
Perineurial Cells, donor1	11499-119F5	50.41	31.87	10.85	7.12	1.47	0.68	2.49	0.79	1.24	1.02
Perineurial Cells, donor2	11579-120F4	57.60	32.76	12.15	10.12	4.05	2.39	3.59	1.20	1.10	0.92
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	55.46	42.71	11.47	8.29	0.96	2.55	3.51	1.91	0.32	0.32
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	30.12	27.91	13.71	5.14	0.98	1.96	0.98	0.49	0.24	0.49
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	25.62	24.59	10.87	5.56	0.78	1.29	0.91	0.26	0.91	0.39
Placental Epithelial Cells, donor1	11278-116H9	15.55	15.07	5.98	2.63	0.72	0.72	0.96	0.72	0.24	0.24
Placental Epithelial Cells, donor2	11355-117H5	22.18	12.20	6.65	3.33	0.00	0.00	0.00	0.00	1.11	2.22
Placental Epithelial Cells, donor3	11427-118G5	14.92	11.98	7.07	1.96	0.59	0.39	0.20	0.20	0.79	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	26.58	25.63	12.97	5.38	1.58	0.95	1.27	0.32	1.58	1.27
Preadipocyte - breast, donor1	11467-119B9	37.71	25.32	13.13	5.63	1.13	0.94	0.56	0.56	1.13	0.94
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	36.29	27.41	6.27	7.18	0.91	0.26	1.70	1.83	0.65	1.31
Preadipocyte - breast, donor2	11328-117E5	30.17	21.16	13.06	6.08	0.45	0.45	1.35	0.68	0.68	0.90
Preadipocyte - omental, donor1	11468-119C1	49.23	25.68	16.84	7.25	1.92	0.96	1.28	1.17	0.96	0.43
Preadipocyte - omental, donor2	11329-117E6	46.27	23.57	10.48	8.73	2.18	2.18	0.44	0.44	2.62	0.00
Preadipocyte - omental, donor3	11403-118D8	37.67	18.77	8.17	4.01	2.15	0.86	2.15	1.72	0.57	0.86
Preadipocyte - perirenal, donor1	11469-119C2	22.64	18.70	5.91	3.94	0.98	0.98	0.98	0.98	0.98	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	18.12	11.36	6.14	4.91	1.23	0.61	0.31	0.61	0.31	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	36.12	24.61	19.83	8.85	2.66	0.71	3.54	1.77	1.06	1.24
Preadipocyte - subcutaneous, donor3	11428-118G6	37.29	24.18	11.92	7.83	3.07	1.53	3.41	1.02	1.36	1.02
Preadipocyte - visceral, donor1	11280-116I2	49.74	28.88	11.08	8.20	2.42	1.40	2.70	1.86	0.84	1.02
Preadipocyte - visceral, donor2	11357-117H7	41.88	21.17	17.03	8.28	3.68	1.84	0.46	1.38	0.00	0.92
Preadipocyte - visceral, donor3	11429-118G7	39.60	26.12	14.00	8.46	1.57	1.04	1.99	1.15	0.63	1.15
Prostate Epithelial Cells (polarized), donor1	11253-116F2	35.90	25.49	15.84	9.20	3.77	3.02	1.96	1.21	1.21	0.15
Prostate Epithelial Cells, donor2	11331-117E8	42.79	11.10	7.58	6.36	4.60	1.62	1.22	1.08	0.95	0.95
Prostate Epithelial Cells, donor3	11404-118D9	55.36	19.60	6.61	3.43	2.57	0.49	1.59	1.35	0.43	1.47
Prostate Stromal Cells, donor1	11254-116F3	40.78	24.26	12.07	7.86	4.21	1.25	3.99	1.37	1.37	1.37
Prostate Stromal Cells, donor2	11332-117E9	35.32	20.26	10.40	8.25	4.30	1.26	3.23	1.43	0.54	0.90
Prostate Stromal Cells, donor3	11405-118E1	32.22	20.44	11.47	5.01	1.36	0.10	1.36	0.63	0.73	0.83
Renal Cortical Epithelial Cells, donor1	11516-119H4	33.58	14.60	1.82	1.09	0.00	0.00	0.36	1.09	0.36	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	59.82	19.68	9.29	7.21	1.46	0.83	1.25	1.80	1.46	0.90
Renal Epithelial Cells, donor1	11517-119H5	20.29	7.61	2.54	1.52	0.51	0.00	0.51	1.01	0.51	0.00
Renal Epithelial Cells, donor2	11597-120H4	14.23	12.80	3.56	0.71	0.00	0.00	0.00	1.42	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	62.78	22.87	10.48	7.94	1.80	0.42	1.16	1.80	0.53	1.80
Renal Glomerular Endothelial Cells, donor1	11514-119H2	21.79	17.02	2.72	3.40	1.36	0.00	0.00	0.00	0.00	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	22.64	14.15	4.58	4.58	0.94	0.54	0.67	0.13	0.54	0.27
Renal Glomerular Endothelial Cells, donor3	11675-122H1	37.96	21.76	12.43	5.77	2.66	1.55	2.22	0.67	0.89	1.11
Renal Glomerular Endothelial Cells, donor4	11783-124B1	13.97	4.66	0.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	24.87	16.07	2.64	4.18	2.64	0.66	0.44	0.88	0.22	0.44
Renal Mesangial Cells, donor2	11598-120H5	18.18	13.17	4.39	4.39	1.25	0.00	1.25	0.63	0.00	1.25
Renal Mesangial Cells, donor3	11679-122H5	13.32	7.49	2.22	1.66	0.00	0.00	0.00	0.55	0.00	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	46.44	23.08	4.03	7.52	1.88	0.00	0.54	2.15	0.00	0.54
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	31.63	12.23	4.22	0.42	1.69	0.00	0.42	0.84	0.00	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	20.83	14.66	3.66	3.86	1.16	0.19	0.58	1.16	0.19	0.58
Retinal Pigment Epithelial Cells, donor0	11215-116A9	69.75	37.08	10.89	6.48	1.30	1.81	1.30	1.81	0.00	2.07
Retinal Pigment Epithelial Cells, donor1	11528-119I7	51.73	27.86	8.24	4.26	1.99	0.85	1.14	0.57	0.57	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	19.55	10.29	0.00	2.06	0.00	1.03	0.00	0.00	1.03	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	62.48	36.38	21.08	9.28	2.01	0.75	1.51	1.51	1.00	0.50
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	47.84	51.18	19.78	17.11	2.54	1.74	2.00	1.74	1.87	0.67
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	60.75	39.31	22.34	8.04	2.68	3.57	5.36	1.79	2.68	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	111.17	79.80	30.27	20.36	3.85	4.95	6.60	2.20	2.20	2.75
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	81.21	53.37	21.46	8.70	5.22	4.06	3.48	5.80	0.58	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	56.17	41.09	18.59	13.26	4.42	4.68	1.56	3.12	1.04	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	35.25	31.18	14.20	8.04	3.18	2.28	1.79	1.49	0.99	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	59.00	42.05	13.27	14.28	4.24	4.02	3.12	1.90	1.67	0.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	65.00	59.29	16.37	16.00	3.72	3.47	4.34	2.48	0.87	1.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	41.02	33.10	14.68	8.51	2.80	2.45	3.15	1.17	0.47	0.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	58.94	38.60	18.95	13.41	3.00	3.24	3.93	3.00	0.92	0.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	37.24	36.97	14.38	8.76	2.05	2.05	3.01	1.64	0.41	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	43.11	34.64	15.13	10.44	2.27	2.42	2.12	1.21	1.06	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	49.46	35.84	13.80	12.72	3.23	3.40	2.15	1.79	0.36	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	35.29	37.16	12.62	10.90	2.15	1.58	3.73	1.29	0.43	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	39.17	28.22	11.27	7.94	3.00	1.82	2.79	1.40	0.54	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	44.70	32.75	13.05	11.51	3.10	2.66	2.43	2.21	1.55	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	38.04	33.46	13.96	10.51	3.82	2.49	3.63	1.91	0.38	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	38.57	30.56	13.79	8.20	3.26	2.89	3.26	1.58	0.84	0.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	68.96	40.78	11.84	13.15	3.01	2.63	3.38	3.38	1.50	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	42.20	37.56	14.73	11.28	2.92	2.52	2.26	2.39	0.27	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	41.66	29.20	14.31	10.22	2.24	2.34	2.82	1.27	1.07	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	46.78	34.75	17.00	9.74	4.20	2.10	5.16	1.15	1.34	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	39.30	31.50	14.31	9.93	2.03	2.35	2.88	2.46	1.28	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	42.61	29.71	13.73	8.69	3.64	1.96	3.08	2.80	1.96	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	39.14	26.49	11.62	9.74	2.73	1.37	1.88	2.05	1.54	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	42.12	36.28	17.32	11.49	2.92	3.10	2.37	2.37	0.91	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	32.87	28.82	13.61	7.36	3.43	2.33	2.58	2.45	1.59	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	41.10	31.83	14.51	9.13	2.96	3.76	2.69	2.96	1.88	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	55.43	39.39	14.62	12.50	3.77	2.36	2.36	4.01	1.18	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	42.86	28.77	14.09	9.33	2.58	3.37	2.98	1.39	0.99	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	45.60	33.91	11.69	11.93	2.81	2.57	3.98	2.10	1.40	1.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	40.64	34.42	13.89	9.75	4.35	3.94	3.53	1.87	1.45	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	45.35	32.52	14.60	9.95	2.43	2.88	2.43	1.77	1.11	1.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	34.88	29.24	13.79	9.82	1.25	3.13	1.25	1.88	1.04	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	38.76	34.72	12.92	9.02	4.04	3.23	2.42	2.56	0.67	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	36.27	29.12	12.09	8.86	2.90	3.24	1.53	1.53	0.85	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	41.26	29.88	14.27	9.45	2.70	3.66	2.51	1.74	1.35	0.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	35.59	41.27	13.58	10.32	2.75	3.27	3.95	2.92	1.20	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	32.10	30.04	14.81	8.64	2.19	3.02	2.19	1.78	1.10	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	45.80	36.28	18.22	8.70	3.28	2.63	3.12	2.79	0.49	1.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	40.90	34.26	11.42	9.54	3.07	2.39	3.92	1.87	0.34	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	42.17	34.03	12.43	9.77	2.81	2.96	2.96	1.04	1.48	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	38.12	24.79	13.33	6.93	1.60	1.87	1.60	2.67	1.87	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	53.09	44.66	22.12	13.55	3.04	5.25	4.15	2.21	1.38	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	44.05	34.76	14.52	12.14	2.38	1.90	3.81	2.14	1.43	0.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	54.62	31.64	16.93	8.26	3.22	4.03	2.22	3.83	0.81	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	47.75	39.93	19.02	13.75	4.05	6.59	3.39	2.17	1.51	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	47.86	46.81	21.66	15.37	3.84	2.45	3.84	3.14	0.35	1.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	43.82	35.36	23.57	6.35	3.93	6.65	4.53	1.21	2.12	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	41.12	43.08	14.93	12.48	3.06	4.41	3.79	2.20	0.61	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	85.44	70.30	41.19	17.61	5.09	14.70	3.64	3.06	4.37	1.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	58.41	55.98	33.46	15.21	4.87	9.13	4.26	2.43	1.22	1.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	54.85	50.64	15.97	12.36	2.41	3.01	3.01	2.41	1.21	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	58.13	54.06	21.49	15.38	5.20	5.20	6.33	3.39	1.13	1.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	61.71	52.72	25.46	12.88	4.49	3.59	5.99	2.70	1.50	1.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	65.89	71.67	33.77	23.85	4.96	10.51	3.66	3.66	1.89	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	60.62	52.93	25.61	16.01	3.20	4.48	7.26	2.13	2.99	1.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	53.49	47.48	14.42	9.01	0.60	0.60	0.60	3.00	4.21	0.00
Schwann Cells, donor1	11498-119F4	17.30	10.91	2.07	2.44	0.38	0.19	0.75	0.94	0.38	0.19
Schwann Cells, donor2	11578-120F3	10.21	40.83	0.00	3.40	6.80	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	25.85	18.62	10.95	4.82	1.75	0.22	1.97	0.44	1.75	1.75
Sebocyte, donor1	11220-116B5	37.80	8.76	3.29	4.38	3.29	1.64	1.64	0.55	0.00	0.55
Sebocyte, donor2	11301-117B5	33.09	10.11	6.89	2.76	0.92	0.92	0.46	0.92	0.46	1.38
Sebocyte, donor3	11378-118B1	25.97	7.63	6.60	4.53	0.62	0.21	1.03	0.21	0.62	1.03
Sertoli Cells, donor1	11255-116F4	62.95	28.16	16.57	8.28	0.00	3.31	3.31	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	45.19	28.24	2.82	0.00	0.00	0.00	0.00	2.82	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	39.50	34.22	15.84	8.45	2.55	2.20	2.11	0.88	1.41	0.62
Skeletal Muscle Cells, donor2	11358-117H8	6.51	10.12	7.23	0.00	0.72	0.00	0.72	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	21.74	13.38	10.87	3.34	0.84	0.84	0.84	0.00	0.00	0.84
Skeletal Muscle Cells, donor4	11451-119A2	52.00	25.76	10.68	7.85	0.47	0.63	0.79	1.89	1.26	0.63
Skeletal Muscle Cells, donor5	11455-119A6	46.38	23.49	10.41	6.24	0.89	0.74	1.49	2.23	0.74	1.04
Skeletal Muscle Cells, donor6	11459-119B1	48.63	23.70	12.62	8.00	2.00	1.08	2.00	1.69	0.46	1.23
Skeletal Muscle Satellite Cells, donor1	11240-116D7	61.62	39.69	23.31	8.82	1.39	1.26	1.64	1.76	1.64	1.51
Skeletal Muscle Satellite Cells, donor2	11321-117D7	39.95	24.97	22.26	5.42	0.57	0.57	2.71	0.71	1.57	0.86
Skeletal Muscle Satellite Cells, donor3	11397-118D2	45.44	23.02	13.69	7.64	1.59	1.09	2.28	2.08	1.98	0.69
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	42.38	30.25	17.27	5.48	2.19	2.78	2.02	1.26	1.94	0.42
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	24.61	13.03	7.24	2.17	0.72	0.00	1.45	0.00	1.45	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	20.78	17.48	8.53	6.47	1.10	0.96	1.38	0.28	0.83	0.55
Skin - palm, donor1	10286-104F7	26.86	21.49	45.66	2.69	0.00	5.37	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	30.71	8.65	5.62	4.04	2.74	0.72	1.01	0.86	0.86	0.86
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	91.60	21.27	9.00	4.91	10.63	0.82	4.09	13.09	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	27.52	10.91	6.23	3.64	1.56	0.39	0.65	0.78	0.65	0.52
Small Airway Epithelial Cells, donor1	11256-116F5	55.60	21.96	13.07	5.56	4.17	1.11	1.25	1.39	0.56	0.56
Small Airway Epithelial Cells, donor2	11334-117F2	28.83	14.07	14.63	4.50	2.11	3.09	0.84	0.42	1.41	0.70
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	77.81	33.41	16.07	11.21	6.13	4.23	1.69	3.81	1.48	1.06
Small Airway Epithelial Cells, donor3	11406-118E2	34.70	18.14	9.52	5.85	0.97	0.75	0.90	1.57	0.82	0.60
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	31.17	8.64	4.01	1.85	0.93	0.93	1.23	2.47	0.00	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	60.03	58.70	33.13	18.45	7.78	2.67	4.67	2.67	1.11	1.33
Smooth Muscle Cells - Aortic, donor0	11210-116A4	24.69	12.34	5.88	4.70	0.59	1.18	1.76	0.00	1.76	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	29.39	16.57	5.75	4.86	1.33	0.88	0.88	0.22	0.22	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	19.30	14.57	3.15	3.94	3.54	0.39	1.18	0.39	0.39	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	24.72	16.22	10.82	5.41	1.55	0.77	0.77	0.00	0.77	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	45.03	32.02	19.01	6.00	1.00	1.00	1.00	1.00	1.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	36.60	22.22	6.39	6.12	2.79	1.33	2.00	1.33	0.40	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	51.65	37.68	16.62	9.09	2.22	1.33	3.32	0.66	2.22	1.55
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	32.01	14.21	13.83	5.38	2.18	1.66	1.41	1.02	0.64	0.38
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	42.00	25.07	9.12	7.81	1.63	1.30	2.60	1.63	0.65	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	43.12	29.83	11.52	8.27	1.48	0.59	3.54	0.59	0.89	2.36
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	26.76	12.53	5.27	4.70	1.42	1.00	2.70	1.42	0.85	1.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	19.52	10.41	1.14	3.25	0.49	0.00	0.49	0.49	0.33	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	30.14	32.88	18.27	6.70	0.91	1.22	1.22	0.91	0.61	1.83
Smooth Muscle Cells - Carotid, donor1	11285-116I7	29.04	26.77	3.28	4.80	0.00	1.01	1.26	0.25	0.25	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	12.24	6.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	18.60	7.63	5.25	2.38	0.48	0.48	0.48	0.00	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	36.72	23.45	9.29	7.82	1.33	0.74	2.36	0.15	0.59	0.74
Smooth Muscle Cells - Colonic, donor2	11320-117D6	33.58	19.16	11.84	7.53	2.15	0.22	3.23	0.65	0.86	0.43
Smooth Muscle Cells - Colonic, donor3	11396-118D1	37.37	22.46	9.13	9.45	2.10	0.84	2.73	0.52	0.73	0.84
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	26.91	12.22	5.72	4.64	1.70	0.46	1.39	0.31	0.31	0.62
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	32.34	8.62	8.62	1.08	2.16	1.08	1.08	1.08	1.08	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	23.01	15.84	7.47	7.47	2.39	0.90	2.99	1.20	0.90	0.90
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	17.75	7.85	1.37	1.02	1.02	0.00	0.68	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	45.15	34.63	19.08	7.85	1.65	0.71	2.04	0.55	1.33	0.71
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	67.03	22.14	16.61	6.04	0.91	0.60	1.51	1.11	1.61	1.51
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	64.17	27.76	25.03	9.56	4.10	2.50	3.19	2.28	1.59	2.50
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	20.53	10.26	5.43	1.81	3.02	1.21	2.42	1.21	1.81	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	62.79	27.02	8.74	8.48	2.65	1.59	1.06	1.85	1.59	2.12
Smooth Muscle Cells - Prostate, donor1	11257-116F6	39.42	29.16	12.12	7.72	2.00	1.33	1.73	1.33	0.67	0.40
Smooth Muscle Cells - Prostate, donor2	11335-117F3	33.06	19.16	13.40	6.64	3.51	0.88	2.13	1.13	0.63	0.88
Smooth Muscle Cells - Prostate, donor3	11465-119B7	29.17	16.49	9.64	3.80	0.76	0.25	1.01	0.76	0.00	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	33.47	22.16	10.10	6.03	3.92	1.36	1.66	1.21	1.06	0.30
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	15.00	21.00	1.50	5.25	0.00	0.00	0.75	0.00	0.00	2.25
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	12.92	7.75	2.58	1.29	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	24.18	14.88	6.51	3.72	0.00	0.00	1.40	0.00	0.93	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	39.38	11.11	9.09	3.03	2.02	1.51	1.51	1.01	0.50	2.02
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	37.61	21.62	15.67	7.21	3.13	1.57	0.94	0.94	0.00	0.94
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	20.65	12.98	2.65	0.88	1.18	0.00	0.88	0.29	0.59	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	42.40	29.82	13.33	9.66	2.92	1.08	2.25	1.17	1.33	0.42
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	28.50	28.03	11.21	6.07	0.93	0.47	1.40	0.00	1.40	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	31.37	12.38	5.32	4.32	2.45	0.58	1.58	0.58	0.72	0.43
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	18.61	11.73	4.84	2.29	1.78	0.51	4.08	0.76	1.02	0.51
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	14.29	11.09	4.70	2.82	1.13	0.75	1.50	0.56	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	47.51	29.77	13.97	6.71	2.24	2.24	2.24	1.68	2.38	1.40
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	47.26	28.74	11.23	5.70	2.77	1.17	1.93	0.92	0.75	1.76
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	5.71	3.33	0.48	0.95	0.00	0.00	1.43	0.48	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	27.40	14.19	3.91	4.16	0.73	0.00	1.22	1.47	0.00	0.98
Smooth Muscle Cells - Uterine, donor1	11258-116F7	39.55	19.89	10.16	6.19	2.43	1.77	1.99	0.88	1.55	0.66
Smooth Muscle Cells - Uterine, donor3	11466-119B8	29.84	16.97	6.14	5.56	0.88	0.59	1.46	1.17	0.00	0.59
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	23.71	20.21	14.97	4.86	0.58	1.17	3.69	1.17	0.97	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	31.47	15.87	12.43	4.50	1.85	1.06	1.59	1.59	1.32	0.53
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	56.16	27.90	20.46	9.30	2.60	1.12	2.60	1.12	0.74	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	38.81	16.17	16.53	7.91	2.16	0.00	2.16	1.44	0.36	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	38.89	17.60	12.78	7.10	4.83	0.57	2.27	1.42	1.99	0.57
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	30.33	18.91	12.60	4.73	3.15	1.97	1.58	0.39	1.18	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	37.84	22.09	14.22	5.59	1.27	0.76	1.52	1.27	1.52	2.29
Smooth muscle cells - airway, control, donor2	11967-126D5	35.54	17.97	5.59	4.79	2.40	0.40	1.60	1.20	1.20	0.80
Smooth muscle cells - airway, control, donor3	11968-126D6	30.51	9.61	14.21	3.34	1.25	0.00	1.25	1.67	0.42	0.84
Smooth muscle cells - airway, control, donor4	11969-126D7	36.67	23.38	11.46	3.67	1.38	0.46	3.21	2.29	0.46	0.46
Synoviocyte, donor1	11291-117A4	42.42	23.06	18.85	6.40	1.18	1.01	0.50	0.84	1.35	0.50
Synoviocyte, donor2	11368-117I9	38.55	31.85	15.25	4.53	1.34	0.67	1.84	0.67	0.50	1.17
Synoviocyte, donor3	11440-118H9	32.84	30.83	11.39	6.26	0.89	0.22	0.45	0.89	0.45	0.89
Trabecular Meshwork Cells, donor1	11532-120A2	24.66	5.72	3.57	3.22	1.07	0.00	1.07	0.36	0.00	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	29.73	5.95	0.00	1.98	0.00	0.00	1.98	1.98	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	19.45	9.96	3.94	2.08	1.62	0.00	0.69	1.16	0.69	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	41.51	11.68	6.52	3.51	1.08	0.50	0.57	0.72	0.72	0.72
Tracheal Epithelial Cells, donor2	11369-118A1	19.33	6.57	1.55	3.09	1.93	1.55	1.55	0.00	0.39	1.16
Tracheal Epithelial Cells, donor3	11441-118I1	17.18	6.87	5.15	2.29	0.00	1.15	0.00	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	46.63	44.66	20.67	15.99	2.83	2.34	1.72	1.48	0.86	1.48
Urethra, donor2	10319-105A4	39.57	39.57	35.97	5.40	0.00	1.80	1.80	3.60	3.60	0.00
Urothelial Cells, donor1	11520-119H8	30.02	13.28	2.13	3.45	2.92	0.00	0.80	0.80	0.27	0.53
Urothelial Cells, donor2	11600-120H7	25.24	12.02	3.61	3.20	2.00	0.00	0.40	1.20	0.00	0.00
Urothelial Cells, donor3	11681-122H7	20.40	6.19	1.15	1.38	0.46	0.23	0.46	0.46	0.46	0.00
Urothelial cells, donor0	11216-116B1	49.93	12.71	6.69	4.90	1.11	0.89	2.90	1.11	0.45	0.89
Whole blood (ribopure), donor090309, donation1	12179-129A1	71.18	47.16	13.35	10.68	0.00	0.89	0.00	4.45	0.89	1.78
Whole blood (ribopure), donor090309, donation2	12180-129A2	75.77	51.47	12.87	10.01	0.00	1.43	1.43	1.43	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	36.96	23.27	8.90	4.79	0.00	0.00	1.37	2.05	0.68	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	49.24	40.63	11.71	8.95	0.00	0.00	1.72	2.41	0.00	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	52.87	36.60	9.30	9.88	0.58	1.16	0.00	2.32	1.16	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	71.85	41.65	8.33	8.33	2.08	0.00	2.08	4.16	1.04	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	69.75	51.40	18.36	18.36	0.92	0.92	0.92	7.34	0.00	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	34.69	22.82	5.48	0.91	0.00	0.91	0.00	3.65	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	38.37	29.61	33.68	8.02	4.32	2.59	3.21	1.48	1.97	1.23
Wilms' tumor cell line:HFWT	10597-108E3	34.32	33.44	17.60	5.28	2.64	0.88	0.00	0.00	0.88	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	46.37	12.57	7.82	2.51	1.68	1.12	1.68	1.40	0.56	0.84
achilles tendon, donor2	10292-104G4	16.53	12.40	12.40	2.07	2.07	2.07	2.07	2.07	0.00	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	74.45	35.69	8.67	13.00	2.29	2.29	2.29	1.78	1.02	2.29
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	74.53	36.68	9.29	5.57	0.93	3.95	2.55	0.70	1.16	0.23
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	87.37	39.53	9.26	11.75	3.09	1.31	3.92	3.68	0.83	0.95
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	84.08	39.73	20.41	8.98	1.90	2.72	1.09	0.54	2.45	2.18
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	32.32	19.11	21.36	7.03	1.69	1.12	3.37	1.12	0.28	0.28
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	68.94	68.52	25.17	11.21	1.06	2.54	2.11	1.06	1.06	1.06
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	61.52	43.83	28.31	16.06	4.90	1.91	1.91	2.99	1.63	0.54
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	107.96	55.52	21.59	12.78	4.41	1.76	2.64	4.41	0.88	1.32
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	64.11	55.13	26.54	12.66	2.04	3.27	2.04	2.04	2.04	1.63
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	50.87	41.55	21.74	8.93	1.55	0.78	1.16	1.16	0.39	1.55
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	57.96	26.68	15.64	5.15	1.47	1.84	1.66	2.76	1.29	1.29
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	50.71	50.71	19.50	11.70	3.90	0.00	0.00	3.90	7.80	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	57.86	38.81	35.32	8.13	4.88	3.95	1.63	1.16	0.70	1.16
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	127.38	70.94	19.16	18.38	4.14	1.04	3.11	4.92	0.52	1.81
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	123.62	59.62	23.38	15.78	1.17	0.58	1.46	4.97	0.58	0.58
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	43.22	22.31	28.35	3.25	0.46	1.86	0.46	1.39	1.39	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	60.04	25.09	6.58	5.76	0.82	0.82	0.82	1.23	0.41	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	41.75	27.01	12.58	4.60	0.61	1.53	1.53	2.46	0.61	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	69.13	40.96	15.79	14.08	1.71	1.28	2.56	2.13	1.71	2.13
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	68.24	44.28	12.74	14.56	1.82	0.91	2.43	1.21	0.91	0.91
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	74.86	44.29	17.09	13.72	4.09	0.96	2.65	2.65	2.17	1.44
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	39.87	16.71	8.69	2.67	1.34	0.45	0.89	2.67	0.22	0.45
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	64.71	28.69	13.68	7.67	2.67	1.33	1.67	1.67	0.00	0.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	72.47	33.45	72.47	11.15	9.29	1.86	1.86	0.00	1.86	3.72
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	94.17	44.45	19.96	14.31	6.03	1.51	1.88	1.13	0.38	1.13
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	50.59	36.20	55.82	8.29	2.18	6.11	0.87	0.00	0.44	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	15.00	20.62	29.99	5.62	0.00	1.87	1.87	0.00	1.87	0.00
adenocarcinoma cell line:IM95m	10796-110I4	48.98	25.67	10.36	8.95	0.24	1.18	1.88	1.88	0.71	1.18
adipose tissue, adult, pool1	10010-101C1	29.63	35.68	9.46	7.60	0.47	0.16	1.40	0.78	0.31	0.62
adipose, donor1	10184-103D4	147.78	114.35	57.47	13.49	3.52	2.35	3.52	4.69	1.76	5.86
adipose, donor2	10185-103D5	45.42	24.33	21.90	5.27	0.81	2.43	0.81	4.06	2.03	1.62
adipose, donor3	10186-103D6	42.75	35.40	32.95	7.08	3.00	4.08	1.09	3.54	2.45	1.63
adipose, donor4	10187-103D7	75.41	28.60	29.47	7.80	0.87	3.47	2.60	6.07	0.87	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	58.71	36.30	18.31	5.52	0.63	0.63	0.95	1.26	2.05	0.63
adrenal gland, adult, pool1	10081-102A9	36.38	25.46	25.46	7.28	0.00	0.00	0.00	3.64	0.00	3.64
adult T-cell leukemia cell line:ATN-1	10421-106C7	50.96	25.88	3.74	5.34	0.67	0.53	0.93	1.87	0.13	1.33
alveolar cell carcinoma cell line:SW 1573	10708-109H6	57.53	38.95	12.86	10.00	1.07	1.79	1.43	2.14	0.36	0.36
amniotic membrane cells, donor1	12235-129G3	44.98	27.82	10.67	3.94	0.00	1.16	0.70	1.62	0.00	1.16
amniotic membrane cells, donor2	12236-129G4	56.46	37.87	11.83	4.40	1.01	1.35	2.70	0.68	0.00	1.35
amniotic membrane cells, donor3	12237-129G5	56.86	23.27	12.67	2.95	0.29	0.29	1.18	1.77	0.59	0.59
amygdala - adult, donor10196	10167-103B5	142.30	39.13	96.05	9.49	7.11	5.93	0.00	21.34	5.93	2.37
amygdala, adult, donor10252	10151-102I7	82.93	56.17	58.19	9.73	0.81	5.47	2.84	6.08	3.85	0.61
amygdala, newborn, donor10223	10360-105E9	101.67	48.42	56.16	13.88	1.29	2.90	2.26	7.75	2.58	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	89.13	54.24	7.51	7.89	1.53	1.27	1.78	2.80	0.13	0.64
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	31.11	24.71	12.35	6.40	6.18	1.99	3.97	0.88	0.44	0.44
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	43.09	50.77	46.43	14.36	2.00	12.03	2.34	1.34	4.01	0.33
aorta, adult, pool1	10052-101G7	25.50	30.01	15.49	3.73	0.00	1.57	1.37	0.98	0.39	1.18
appendix, adult	10189-103D9	48.90	43.08	28.72	9.31	1.16	1.55	1.94	1.55	0.00	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	80.82	67.07	12.73	20.98	4.13	1.72	2.06	0.69	1.72	4.13
artery, adult	10190-103E1	38.04	82.88	28.53	13.59	0.00	2.72	0.00	0.00	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	126.76	127.63	46.36	22.45	2.90	6.37	4.20	2.32	3.91	2.32
b cell line:RPMI1788	10427-106D4	55.76	23.49	5.50	6.54	1.04	1.49	2.53	1.93	0.59	0.74
basal cell carcinoma cell line:TE 354.T	10702-109G9	43.84	24.42	6.66	5.83	0.83	0.55	0.83	0.55	0.00	1.11
bile duct carcinoma cell line:HuCCT1	10432-106D9	53.68	17.96	4.76	5.56	1.79	0.69	2.08	0.89	0.30	1.09
bile duct carcinoma cell line:TFK-1	10496-107C1	71.14	67.45	13.89	11.38	3.85	2.18	3.01	0.67	1.00	0.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	49.77	27.96	6.15	5.59	0.56	1.12	1.68	0.00	1.68	0.00
bladder, adult, pool1	10011-101C2	32.70	44.11	18.47	6.95	0.43	0.43	2.06	1.41	0.65	0.65
blood, adult, pool1	10053-101G8	26.58	17.72	4.43	8.86	0.00	0.00	4.43	2.21	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	24.83	13.70	15.41	2.57	0.86	0.86	2.57	0.00	0.00	0.00
bone marrow, adult	10192-103E3	37.79	47.91	19.57	10.12	0.67	2.02	2.02	0.67	0.00	0.67
brain, adult, donor1	10084-102B3	62.53	38.95	56.38	12.30	1.03	1.03	3.08	4.10	1.03	0.00
brain, adult, pool1	10012-101C3	101.45	76.50	85.52	15.81	3.12	6.90	3.67	5.57	8.24	1.78
brain, fetal, pool1	10085-102B4	32.06	50.76	45.41	8.01	2.67	2.67	2.67	2.67	5.34	0.00
breast carcinoma cell line:MCF7	10482-107A5	43.61	28.08	13.21	4.96	0.66	1.98	1.65	1.98	2.31	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	31.33	45.81	19.85	9.24	0.25	1.37	1.12	0.50	2.25	0.37
breast, adult, donor1	10080-102A8	22.73	21.47	6.31	1.89	0.63	0.00	1.26	2.53	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	39.89	33.79	17.53	4.45	1.14	1.78	1.78	1.78	1.02	0.76
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	66.79	46.38	22.88	7.73	0.62	2.78	2.16	0.00	1.55	1.55
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	69.07	36.84	6.45	8.52	1.38	1.38	1.84	1.84	0.46	1.84
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	32.68	34.38	25.90	6.05	2.42	1.69	1.21	1.45	1.21	0.48
carcinoid cell line:NCI-H1770	10703-109H1	38.08	17.40	1.41	3.76	0.94	0.47	0.00	0.47	1.41	0.47
carcinoid cell line:NCI-H727	10735-110B6	84.33	56.55	17.39	14.11	3.39	1.75	2.84	1.53	1.97	2.19
carcinoid cell line:SK-PN-DW	10719-109I8	77.96	31.69	8.24	9.19	2.22	0.32	0.95	3.49	0.32	0.95
carcinosarcoma cell line:JHUCS-1	10642-109A3	73.47	58.03	31.94	8.78	2.13	2.66	2.13	4.79	1.60	1.06
caudate nucleus - adult, donor10196	10177-103C6	117.43	52.96	86.35	8.06	3.45	1.15	3.45	9.21	10.36	0.00
caudate nucleus, adult, donor10252	10164-103B2	93.03	70.28	65.09	11.38	0.84	5.02	1.00	7.86	5.69	1.34
caudate nucleus, adult, donor10258	10379-105H1	123.03	86.35	80.23	13.75	1.53	3.82	5.35	6.88	5.35	0.76
caudate nucleus, newborn, donor10223	10354-105E3	102.55	85.33	84.97	19.78	1.46	2.20	3.66	8.42	4.03	0.73
cerebellum - adult, donor10196	10173-103C2	99.05	96.14	87.40	11.65	0.00	2.91	0.00	0.00	2.91	0.00
cerebellum, adult, donor10252	10166-103B4	103.98	84.76	42.92	13.24	1.28	1.07	2.56	7.90	1.49	0.64
cerebellum, adult, pool1	10083-102B2	66.23	75.20	66.57	17.59	1.38	0.69	1.38	2.41	2.41	2.76
cerebellum, newborn, donor10223	10357-105E6	102.96	92.16	97.97	15.78	4.15	3.32	2.49	7.47	6.64	0.83
cerebral meninges, adult	10188-103D8	97.58	71.61	118.25	12.61	2.77	5.55	3.28	5.55	11.85	0.76
cerebrospinal fluid, donor2	10294-104G6	32.16	27.77	23.39	4.39	1.46	1.46	1.46	0.73	2.19	1.46
cervical cancer cell line:D98-AH2	10552-107I3	37.38	51.76	28.04	6.61	2.16	2.30	1.87	0.43	1.44	0.86
cervical cancer cell line:ME-180	10553-107I4	47.56	24.36	13.75	5.47	2.65	6.30	1.16	0.50	1.49	0.50
cervix, adult, pool1	10013-101C4	39.37	51.97	25.93	9.97	0.63	0.73	1.36	0.52	1.36	0.63
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	69.39	56.85	11.01	12.26	4.46	1.39	4.60	0.56	0.84	0.84
chondrosarcoma cell line:SW 1353	10700-109G7	18.29	13.06	26.13	1.31	1.31	1.31	1.31	0.00	2.61	0.00
choriocarcinoma cell line:BeWo	10423-106C9	64.25	35.54	27.34	8.20	7.21	1.99	1.24	2.61	1.12	0.50
choriocarcinoma cell line:SCH	10785-110H2	31.67	36.22	12.94	4.93	2.34	1.23	0.49	0.99	0.74	0.37
choriocarcinoma cell line:T3M-3	10618-108G6	36.29	21.11	9.96	3.56	1.66	2.13	0.71	2.13	0.24	1.42
chorionic membrane cells, donor1	12238-129G6	30.77	43.59	16.24	5.98	2.28	2.28	2.28	0.57	2.28	1.99
chorionic membrane cells, donor2	12239-129G7	53.30	33.61	10.94	10.24	2.19	2.09	2.49	1.49	1.49	1.79
chorionic membrane cells, donor3	12240-129G8	44.51	73.63	18.68	9.89	1.10	1.10	1.10	1.10	1.10	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	54.53	36.35	12.12	6.06	3.03	1.01	4.04	0.00	0.00	2.02
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	43.41	28.43	11.53	7.30	3.46	0.96	3.07	1.92	0.96	0.77
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	23.44	26.19	15.21	4.43	1.90	2.32	2.32	0.00	1.90	0.42
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	73.96	31.07	13.61	7.70	1.80	0.51	1.80	3.60	1.28	0.51
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	66.76	30.96	17.66	9.92	2.90	1.69	3.87	1.45	0.97	0.97
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	79.00	34.41	14.66	14.05	4.48	1.02	2.65	3.66	1.02	1.22
chronic myelogenous leukemia cell line:K562	10454-106G4	93.64	54.77	8.54	20.02	4.71	2.65	2.06	1.77	1.18	1.47
chronic myelogenous leukemia cell line:KU812	10409-106B4	107.64	64.90	32.06	18.50	5.73	8.86	4.95	1.82	2.35	1.04
clear cell carcinoma cell line:JHOC-5	10638-108I8	38.63	27.43	10.97	8.46	0.46	0.91	1.14	1.60	0.91	1.14
clear cell carcinoma cell line:TEN	10636-108I6	53.09	22.38	2.08	6.25	1.56	1.04	0.69	1.39	0.00	1.91
colon carcinoma cell line:CACO-2	10513-107D9	47.96	30.20	27.64	7.50	2.93	2.93	0.73	0.92	1.46	0.92
colon carcinoma cell line:COLO-320	10420-106C6	84.76	46.37	16.72	14.06	0.38	3.42	4.18	3.04	0.76	1.14
colon, adult, donor1	10082-102B1	22.61	45.22	20.23	8.33	1.19	1.19	1.19	1.19	2.38	0.00
colon, adult, pool1	10014-101C5	31.26	46.53	19.51	14.69	1.29	0.71	2.82	0.71	1.76	0.82
colon, fetal, donor1	10070-101I7	39.55	46.35	22.25	9.27	0.62	0.62	0.00	2.47	1.24	1.24
common myeloid progenitor CMP, donor1	12130-128D6	68.75	41.25	73.34	9.17	0.00	0.00	0.00	0.00	9.17	0.00
common myeloid progenitor CMP, donor2	12134-128E1	25.04	125.18	75.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	67.56	52.69	15.72	12.75	8.50	2.55	4.25	2.12	0.42	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	48.45	46.03	16.60	12.68	4.08	2.41	2.26	2.11	0.91	0.45
cord blood derived cell line:COBL-a untreated	10449-106F8	59.22	46.67	17.49	12.97	3.67	3.67	1.41	2.26	0.42	0.42
corpus callosum, adult, pool1	10042-101F6	61.03	72.75	46.66	12.05	3.65	4.98	2.32	3.32	5.09	0.66
cruciate ligament, donor2	10295-104G7	32.42	20.26	15.40	3.24	0.81	0.00	0.81	3.24	1.62	0.00
diaphragm, fetal, donor1	10069-101I6	38.52	52.17	19.26	8.03	2.41	0.80	1.61	0.80	0.00	0.80
diencephalon, adult	10193-103E4	79.44	59.76	75.60	9.36	5.28	6.72	3.12	6.24	5.52	0.96
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	52.81	18.60	7.81	5.97	0.46	0.92	1.15	1.38	0.92	1.61
ductal cell carcinoma cell line:KLM-1	10438-106E6	51.54	33.34	12.05	3.08	1.80	1.03	1.03	0.26	1.03	0.51
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	49.11	9.87	10.59	4.57	4.33	2.65	0.96	1.44	0.48	1.20
ductus deferens, adult	10196-103E7	57.81	58.80	23.92	9.47	1.00	0.00	1.00	4.49	1.99	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	43.21	44.65	28.80	2.88	2.88	1.44	1.44	1.44	2.88	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	42.67	54.44	30.90	9.56	0.74	0.00	3.68	3.68	1.47	1.47
dura mater, adult, donor1	10041-101F5	32.37	52.94	23.79	7.19	0.66	2.40	1.57	0.58	1.65	0.25
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	24.87	10.44	29.54	4.89	9.10	11.33	1.11	2.22	2.66	0.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	48.15	18.48	7.45	8.31	4.87	0.86	1.15	2.58	0.29	0.43
embryonic pancreas cell line:1B2C6	10604-108F1	43.78	45.63	21.58	3.08	1.23	2.47	0.00	0.00	1.23	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	66.60	48.13	8.17	6.66	2.42	0.61	1.51	2.42	0.61	0.91
embryonic pancreas cell line:1C3IKEI	10606-108F3	53.10	47.55	18.83	4.94	1.54	0.93	0.93	0.31	0.00	0.31
embryonic pancreas cell line:2C6	10603-108E9	68.30	45.97	19.70	2.63	1.31	0.00	0.00	2.63	1.31	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	56.98	38.55	47.26	4.36	8.72	5.03	2.68	0.67	2.35	1.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	69.78	72.68	15.41	16.67	1.99	1.45	2.36	1.45	0.54	0.36
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	79.12	24.12	8.52	10.61	1.93	0.80	0.32	1.29	0.16	1.77
epidermoid carcinoma cell line:A431	10426-106D3	48.02	10.34	7.89	3.56	1.78	1.11	0.67	0.78	1.00	1.33
epidermoid carcinoma cell line:Ca Ski	10431-106D8	40.03	14.19	3.74	4.07	1.65	0.99	0.55	1.21	0.22	0.55
epididymis, adult	10197-103E8	36.00	64.89	33.07	13.40	0.00	1.47	3.14	1.05	1.47	0.63
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	51.45	39.74	14.55	9.40	2.31	0.89	1.42	1.60	0.89	0.89
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	16.52	16.12	16.52	5.51	4.72	0.39	2.36	1.18	0.79	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	38.40	24.77	9.57	3.41	1.44	2.36	0.52	1.44	0.66	1.18
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	38.88	27.36	13.58	2.85	1.97	2.95	1.08	0.89	1.28	0.69
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	33.16	22.07	10.87	4.03	0.78	1.23	1.57	0.78	0.00	1.12
esophagus, adult, pool1	10015-101C6	38.12	35.36	11.47	7.01	0.53	0.42	0.64	1.49	0.42	0.96
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	53.73	103.95	42.83	21.42	8.14	2.76	5.01	1.00	1.63	0.75
eye - muscle inferior rectus, donor1	10272-104E2	28.97	38.63	62.78	7.24	0.00	4.83	2.41	0.00	9.66	2.41
eye - muscle lateral, donor2	10298-104H1	25.25	27.35	23.15	6.31	2.10	4.21	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	29.76	22.32	56.55	0.00	0.00	7.44	0.00	0.00	2.98	0.00
eye - muscle superior, donor2	10297-104G9	34.39	29.81	38.98	6.88	0.00	1.15	1.15	0.00	1.15	0.00
eye - vitreous humor, donor1	10268-104D7	23.32	18.95	30.61	0.00	1.46	4.37	0.00	1.46	4.37	0.00
eye, fetal, donor1	10054-101G9	48.56	60.00	28.22	4.58	1.53	2.29	1.78	1.27	2.54	0.51
fibrosarcoma cell line:HT-1080	10758-110E2	43.72	18.85	11.80	5.00	2.31	2.69	2.56	1.54	1.03	0.90
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	46.30	13.30	7.83	5.22	0.47	1.19	0.95	1.42	0.95	0.47
frontal lobe, adult, pool1	10040-101F4	113.81	72.62	86.41	17.92	2.91	8.26	4.69	6.29	9.19	1.22
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	75.66	58.25	18.32	11.71	6.00	3.30	1.80	1.50	1.50	1.50
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	54.13	19.29	3.38	6.86	2.38	0.00	3.20	1.65	0.09	1.19
gall bladder, adult	10198-103E9	33.56	55.53	19.80	10.86	1.69	0.97	1.45	1.21	0.48	0.72
gamma delta positive T cells, donor1	11937-126A2	55.83	64.42	10.20	18.25	1.61	0.00	1.61	0.54	2.15	1.61
gamma delta positive T cells, donor2	11938-126A3	48.18	48.93	17.93	12.33	1.49	2.24	1.87	0.37	1.12	0.75
gastric adenocarcinoma cell line:MKN1	10614-108G2	34.43	9.93	6.76	2.96	1.27	1.90	1.06	1.69	0.63	0.84
gastric adenocarcinoma cell line:MKN45	10612-108F9	28.05	22.44	6.19	4.84	2.51	0.77	0.97	0.39	0.77	0.39
gastric cancer cell line:AZ521	10549-107H9	108.87	66.40	30.99	16.07	6.07	2.79	1.15	2.30	2.13	0.66
gastric cancer cell line:GSS	10560-108A2	30.20	21.05	5.49	8.24	0.00	0.00	0.00	0.92	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	136.39	86.81	45.46	25.13	5.48	12.11	3.88	2.06	5.03	2.06
giant cell carcinoma cell line:LU65	10487-107B1	39.47	44.18	9.87	12.85	1.49	0.80	1.95	0.46	0.92	0.46
giant cell carcinoma cell line:Lu99B	10433-106E1	66.34	15.26	9.52	8.26	11.76	0.84	4.48	4.20	0.14	1.82
glassy cell carcinoma cell line:HOKUG	10688-109F4	41.15	39.41	24.19	8.73	1.75	5.74	1.50	0.50	1.25	1.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	43.59	23.75	11.61	7.92	1.90	0.95	2.64	0.53	0.32	0.42
glioblastoma cell line:A172, tech_rep2	10444-106F3	43.26	20.36	14.18	8.01	2.11	1.40	1.97	1.26	0.56	1.12
glioblastoma cell line:T98G	10485-107A8	33.22	20.86	7.84	6.18	1.77	0.55	2.98	0.77	0.55	0.44
glioma cell line:GI-1	10413-106B8	31.34	30.17	8.79	6.74	4.10	0.59	2.05	0.59	0.00	0.59
globus pallidus - adult, donor10196	10175-103C4	59.77	47.38	77.26	10.20	5.83	3.64	2.19	8.75	2.19	1.46
globus pallidus, adult, donor10252	10161-103A8	67.61	53.21	47.35	10.01	1.46	1.46	1.95	2.69	3.17	0.73
globus pallidus, adult, donor10258	10367-105F7	39.71	35.60	42.45	9.58	1.37	5.48	2.74	9.58	1.37	0.00
globus pallidus, newborn, donor10223	10364-105F4	42.10	38.37	45.83	9.59	2.13	1.60	1.60	5.86	1.60	1.07
granulocyte macrophage progenitor, donor1	12131-128D7	39.15	39.15	22.02	7.34	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	43.71	21.86	10.93	10.93	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	26.13	20.91	15.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	35.20	19.84	13.76	3.20	0.96	0.32	1.60	0.96	0.64	0.32
hIPS +CCl2, biol_rep1	14383-156B9	59.23	27.09	36.27	4.59	6.43	5.05	0.46	1.84	2.75	0.92
hIPS +CCl2, biol_rep2	14384-156C1	69.96	25.61	32.92	4.57	6.86	2.29	0.91	4.12	1.37	0.91
hIPS +CCl2, biol_rep3	14385-156C2	51.53	28.34	20.61	1.29	3.22	2.58	1.93	3.22	2.58	0.00
hIPS, biol_rep1	14380-156B6	44.56	18.68	25.87	0.00	2.87	1.44	1.44	5.75	0.00	0.00
hIPS, biol_rep2	14381-156B7	54.87	28.12	26.06	2.06	2.74	4.80	0.69	2.74	0.69	0.00
hIPS, biol_rep3	14382-156B8	91.59	44.14	75.04	8.83	1.10	4.41	1.10	8.83	5.52	1.10
hairy cell leukemia cell line:Mo	10712-109I1	39.94	21.26	15.80	8.91	0.86	2.30	1.72	1.15	0.57	1.15
heart - mitral valve, adult	10205-103F7	35.28	46.64	27.21	10.76	0.60	0.90	2.09	0.90	3.29	0.00
heart - pulmonic valve, adult	10206-103F8	33.99	60.40	40.79	10.46	1.57	1.31	1.57	0.52	1.83	0.78
heart - tricuspid valve, adult	10207-103F9	30.81	37.47	14.15	7.49	0.00	0.83	1.67	1.67	1.67	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	50.61	38.77	20.41	5.51	0.20	2.24	0.61	0.41	1.02	1.02
heart, adult, diseased, donor1	10051-101G6	31.94	32.79	17.88	5.54	0.43	0.85	1.28	0.43	0.85	0.85
heart, adult, pool1	10016-101C7	22.77	34.50	34.50	5.98	0.69	1.84	0.23	0.92	1.15	0.00
heart, fetal, pool1	10046-101G1	50.62	73.52	28.13	13.35	1.64	2.88	1.85	2.26	2.67	0.51
hepatic mesenchymal tumor cell line:LI90	10778-110G4	30.85	15.43	12.03	4.94	2.16	0.62	2.78	0.93	0.31	1.23
hepatoblastoma cell line:HuH-6	10633-108I3	26.16	16.65	22.59	0.00	1.19	0.00	1.19	2.38	3.57	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	24.97	15.80	15.36	5.97	2.10	0.77	1.88	0.88	0.33	0.77
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	28.77	14.56	18.69	6.07	4.13	2.18	1.94	0.73	0.97	0.85
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	30.01	14.96	16.17	5.46	3.03	1.72	1.72	0.61	0.71	0.71
hepatoma cell line:Li-7	10484-107A7	52.61	56.28	26.36	16.90	8.90	1.78	4.56	0.44	1.00	1.22
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	51.15	21.00	17.19	4.12	2.41	5.03	3.02	1.31	1.71	1.21
hippocampus - adult, donor10196	10169-103B7	112.61	51.10	100.31	9.46	10.41	4.73	4.73	16.09	3.79	0.95
hippocampus, adult, donor10252	10153-102I9	77.15	45.92	50.41	10.20	1.02	4.08	2.45	3.67	5.71	0.61
hippocampus, adult, donor10258	10374-105G5	82.16	46.81	67.72	3.49	4.98	6.47	2.49	7.47	5.98	0.00
hippocampus, newborn, donor10223	10363-105F3	64.50	31.02	74.02	8.46	3.17	3.17	2.47	7.40	6.34	1.06
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	189.21	71.41	32.35	10.99	5.49	0.61	1.83	6.10	2.44	4.88
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	84.24	32.40	18.46	8.64	1.37	0.59	0.98	3.93	1.77	0.98
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	98.26	34.53	20.06	7.36	1.52	0.51	1.02	4.57	1.27	0.51
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	49.62	32.70	24.25	13.53	0.56	0.00	0.56	3.38	2.26	1.69
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	76.17	51.38	27.89	14.98	2.32	0.77	1.81	3.10	0.52	6.20
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	68.71	43.66	31.51	11.77	3.42	1.52	0.76	2.28	1.90	1.14
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	39.41	40.29	31.82	8.17	7.88	3.50	0.88	3.80	2.04	3.50
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	41.79	43.95	31.67	8.19	4.09	3.88	1.94	3.23	1.29	1.72
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	31.70	35.03	36.29	6.67	8.76	5.42	2.09	2.09	1.67	1.67
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	56.12	64.41	20.36	10.66	6.87	2.37	1.89	2.13	0.47	2.13
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	48.05	61.07	30.21	9.96	4.18	3.70	2.73	3.21	1.29	1.77
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	57.23	51.84	33.67	11.45	8.08	2.02	1.35	1.35	0.00	1.35
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	96.55	43.82	18.47	7.20	2.97	0.94	1.41	3.91	0.31	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	113.00	47.16	26.53	10.81	6.39	1.97	0.98	3.93	1.97	6.88
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	202.48	88.15	41.89	17.46	5.24	2.62	0.00	6.11	5.24	2.62
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	69.87	46.77	29.21	11.07	1.53	1.53	1.72	2.48	1.72	0.57
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	67.16	43.61	27.47	8.72	0.44	0.87	0.87	4.80	2.62	1.31
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	107.45	64.47	36.48	14.99	3.50	0.00	2.00	4.00	0.50	3.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	40.88	38.62	26.37	10.17	2.26	3.01	1.70	3.77	1.51	1.32
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	47.75	39.56	36.83	7.28	4.55	3.64	3.18	2.73	2.73	1.36
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	46.36	30.38	33.83	7.83	4.39	2.19	0.94	3.13	3.13	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	49.97	46.21	33.48	12.41	3.27	3.10	2.29	1.80	2.78	1.47
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	51.09	53.71	35.71	8.71	4.94	3.48	2.32	2.03	2.32	1.74
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	51.12	42.75	37.37	6.28	4.18	1.79	2.09	3.89	3.59	2.39
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	96.44	42.12	29.19	12.38	2.22	1.66	1.85	3.51	2.03	1.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	88.72	41.08	28.53	8.27	3.71	3.14	1.43	3.42	1.14	2.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	137.19	58.39	56.76	11.43	5.31	2.86	2.04	6.12	4.08	2.04
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	73.94	46.83	20.77	8.45	2.82	1.41	0.35	4.58	1.76	3.17
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	71.27	31.36	21.54	7.60	3.80	1.27	0.32	2.22	1.27	1.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	58.41	44.49	28.14	9.99	1.51	1.82	1.51	1.82	1.82	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	36.20	33.10	26.37	5.17	2.07	1.55	0.52	3.10	3.10	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	47.16	36.53	21.25	2.66	4.65	2.66	0.66	1.33	1.99	1.99
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	23.60	23.60	29.24	4.36	3.08	2.31	2.05	0.51	2.05	0.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	45.25	47.55	37.58	10.48	5.11	3.32	1.53	3.07	1.79	2.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	42.40	44.68	41.65	10.60	3.03	2.27	0.76	1.51	0.76	1.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	43.35	44.70	36.97	10.42	5.38	2.69	2.69	2.69	2.35	0.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	93.70	42.02	25.60	7.73	1.21	2.17	1.45	3.62	1.69	1.93
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	131.02	59.27	41.00	14.26	4.90	3.12	3.12	2.67	3.57	2.23
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	92.20	40.00	31.71	2.44	2.44	1.95	1.46	2.93	1.95	2.93
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	69.07	40.95	27.51	8.25	3.67	2.44	1.22	2.14	1.53	2.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	448.95	452.20	143.14	55.31	26.03	19.52	6.51	13.01	6.51	19.52
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	102.59	64.86	40.37	14.56	4.30	1.65	2.98	6.29	2.32	3.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	43.78	28.46	27.91	3.83	5.47	2.74	1.64	2.74	3.28	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	38.00	32.93	35.10	7.24	3.26	1.81	2.53	2.53	2.17	1.81
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	33.81	36.65	39.50	7.12	7.47	2.49	1.42	2.85	1.42	1.07
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	44.16	39.38	25.06	9.55	4.77	0.00	0.00	3.58	2.39	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	50.92	63.92	44.15	13.00	7.31	4.06	2.84	3.93	2.03	0.95
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	34.75	37.45	31.25	8.35	5.93	2.69	2.96	2.42	3.50	1.35
immature langerhans cells, donor1	11904-125F5	11.38	13.56	27.36	4.60	0.48	3.87	0.97	0.48	2.18	0.00
immature langerhans cells, donor2	11905-125F6	10.30	23.76	19.80	4.75	0.00	0.00	0.00	0.79	2.38	0.79
insula, adult, pool1	10039-101F3	100.12	64.63	80.25	15.43	3.79	8.04	3.50	5.87	9.94	0.95
keratoacanthoma cell line:HKA-1	10791-110H8	17.56	16.91	5.53	5.20	0.33	2.60	2.93	0.00	0.33	0.65
kidney, adult, pool1	10017-101C8	48.76	64.48	24.53	19.62	1.50	3.80	2.50	1.40	1.80	1.30
kidney, fetal, pool1	10045-101F9	38.76	40.96	14.93	8.35	1.13	1.20	1.56	1.34	1.49	0.21
large cell lung carcinoma cell line:IA-LM	10509-107D5	72.00	62.92	25.00	13.49	5.11	2.41	3.12	1.28	2.98	0.57
large cell lung carcinoma cell line:NCI-H460	10839-111E2	37.88	29.86	28.34	5.81	1.52	6.64	2.35	0.28	1.80	1.24
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	25.51	19.82	4.95	3.49	2.57	0.73	0.37	0.73	0.18	0.18
left atrium, adult, donor1	10079-102A7	29.42	41.41	27.24	4.36	0.00	1.63	0.00	0.54	0.00	0.54
left ventricle, adult, donor1	10078-102A6	22.25	36.91	29.83	7.08	0.51	1.52	2.02	1.01	2.02	1.01
leiomyoblastoma cell line:G-402	10721-110A1	32.83	27.63	22.16	5.47	3.83	0.27	4.38	0.82	0.82	1.09
leiomyoma cell line:10964C	10569-108B2	38.08	16.88	11.14	9.70	2.16	1.44	2.87	1.44	1.08	1.08
leiomyoma cell line:15242A	10570-108B3	44.02	17.39	10.87	6.52	2.72	1.09	2.72	2.17	1.63	0.54
leiomyoma cell line:15425	10571-108B4	44.68	22.10	13.84	9.47	1.94	0.97	3.64	0.73	1.21	3.16
leiomyosarcoma cell line:Hs 5.T	10722-110A2	38.10	44.45	25.40	12.70	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	48.10	19.87	1.05	6.27	1.05	1.05	2.09	2.09	0.00	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	55.61	34.71	26.21	12.63	9.68	8.38	3.42	0.71	4.25	1.18
liposarcoma cell line:KMLS-1	10782-110G8	54.83	44.99	22.96	13.28	6.25	3.75	3.44	1.72	1.25	1.41
liposarcoma cell line:SW 872	10726-110A6	28.75	20.59	16.08	4.75	1.46	2.56	1.95	0.12	1.58	0.24
liver, adult, pool1	10018-101C9	38.73	50.89	21.88	17.99	2.27	3.57	5.35	1.13	1.78	0.97
liver, fetal, pool1	10086-102B5	22.58	22.58	10.35	3.76	0.94	1.88	1.88	0.00	0.00	0.94
locus coeruleus - adult, donor10196	10182-103D2	75.54	37.62	51.77	10.79	3.50	4.23	1.90	5.69	3.94	0.73
locus coeruleus, adult, donor10252	10165-103B3	78.99	52.78	49.09	10.70	4.24	5.72	2.03	4.43	4.06	2.21
locus coeruleus, adult, donor10258	10375-105G6	69.97	51.35	64.05	11.57	7.34	2.82	4.23	11.00	4.51	1.69
locus coeruleus, newborn, donor10223	10362-105F2	117.77	94.64	55.10	21.03	3.36	2.10	5.47	10.09	2.10	0.84
lung adenocarcinoma cell line:A549	10499-107C4	49.68	28.65	16.33	6.37	1.25	0.28	0.42	0.97	1.52	1.11
lung adenocarcinoma cell line:PC-14	10408-106B3	37.23	17.24	4.14	7.58	1.38	1.38	2.76	0.69	0.00	1.38
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	39.94	29.53	15.03	6.20	1.85	1.19	2.77	1.19	1.05	1.32
lung, adult, pool1	10019-101D1	32.96	39.10	10.28	5.91	0.47	0.59	1.18	0.71	1.18	0.59
lung, fetal, donor1	10068-101I5	84.20	76.20	29.97	10.85	1.43	0.57	2.00	3.71	1.71	0.00
lung, right lower lobe, adult, donor1	10075-102A3	38.95	45.82	19.70	5.04	0.00	0.00	2.29	1.37	0.92	1.37
lymph node, adult, donor1	10077-102A5	33.61	49.23	12.31	8.05	0.00	0.00	0.47	0.47	0.47	0.47
lymphangiectasia cell line:DS-1	10727-110A7	55.89	34.63	10.74	5.26	0.66	1.97	2.85	1.75	0.44	1.53
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	34.26	20.07	3.02	5.13	0.60	0.60	0.45	0.45	0.30	0.45
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	46.72	21.24	15.29	5.10	5.95	1.70	1.70	2.55	0.00	0.00
mature adipocyte, donor1	12231-129F8	37.74	34.19	9.77	8.88	0.44	0.00	1.33	1.78	0.89	0.89
mature adipocyte, donor2	12232-129F9	46.07	44.62	10.58	7.26	0.42	0.83	0.83	0.83	0.62	0.21
mature adipocyte, donor3	12233-129G1	41.01	52.15	9.01	6.87	0.47	0.71	1.42	1.19	0.24	0.71
mature adipocyte, donor4	12234-129G2	51.06	65.01	12.11	8.16	0.26	0.53	2.63	1.05	1.05	1.84
maxillary sinus tumor cell line:HSQ-89	10414-106B9	67.90	67.90	20.49	11.20	0.71	2.38	1.19	2.14	0.95	0.95
medial frontal gyrus - adult, donor10196	10170-103B8	151.16	55.27	131.98	13.54	5.64	9.02	6.77	10.15	7.90	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	99.13	54.25	59.22	13.61	2.02	5.89	1.66	6.44	5.52	1.29
medial frontal gyrus, adult, donor10258	10368-105F8	118.82	66.71	103.88	13.34	4.77	6.04	2.86	13.34	6.04	0.95
medial frontal gyrus, newborn, donor10223	10352-105E1	211.11	139.04	165.05	29.00	3.41	4.69	9.38	23.88	9.81	3.41
medial temporal gyrus - adult, donor10196	10183-103D3	165.38	77.79	128.76	20.93	2.70	5.40	2.53	15.86	8.27	8.94
medial temporal gyrus, adult, donor10252	10156-103A3	89.35	47.54	64.94	8.91	1.49	4.88	4.03	6.79	7.00	0.21
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	100.17	42.38	78.98	9.63	3.85	5.78	0.00	26.97	1.93	1.93
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	186.60	200.95	143.54	28.71	14.35	14.35	0.00	14.35	14.35	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	100.86	61.02	101.22	15.08	1.79	3.59	5.03	13.28	4.31	0.72
medulla oblongata - adult, donor10196	10174-103C3	66.84	49.97	46.08	11.03	1.30	5.84	0.65	3.24	4.54	0.65
medulla oblongata, adult, donor10252	10155-103A2	66.41	54.34	29.10	10.53	2.48	3.10	2.32	3.41	2.48	0.31
medulla oblongata, adult, pool1	10038-101F2	64.16	48.24	40.65	10.12	2.37	5.96	1.88	3.02	4.49	0.41
medulla oblongata, newborn, donor10223	10361-105F1	49.65	50.34	41.31	9.37	1.39	2.43	0.69	3.82	3.12	0.69
medulloblastoma cell line:D283 Med	10838-111E1	74.17	64.87	65.10	14.39	8.41	10.85	2.44	5.09	6.42	1.33
medulloblastoma cell line:ONS-76	10759-110E3	33.75	13.21	12.11	2.57	2.81	3.18	1.59	1.59	1.59	0.49
melanoma cell line:COLO 679	10514-107E1	56.06	27.31	9.49	7.19	2.59	1.29	2.16	2.59	0.57	1.58
melanoma cell line:G-361	10465-106H6	32.03	30.40	11.40	6.52	2.44	1.09	2.99	1.36	0.00	0.81
meningioma cell line:HKBMM	10691-109F7	37.27	30.75	5.79	7.78	1.09	0.36	2.35	0.90	0.18	1.45
merkel cell carcinoma cell line:MKL-1	10843-111E6	71.37	101.33	62.56	22.03	5.29	7.93	1.76	1.76	1.76	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	57.55	52.10	33.96	9.07	6.48	4.93	2.33	1.30	1.81	1.81
mesenchymal precursor cell - adipose, donor1	11747-123G1	57.38	36.98	16.11	11.97	2.92	1.69	1.69	1.07	0.31	1.07
mesenchymal precursor cell - adipose, donor2	11748-123G2	32.36	28.36	16.91	6.00	2.00	1.82	1.82	1.09	2.00	0.55
mesenchymal precursor cell - adipose, donor3	11749-123G3	43.89	25.26	11.18	8.70	0.83	0.83	0.83	1.66	0.00	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	34.70	26.69	7.87	5.48	0.28	0.56	1.26	0.70	0.56	1.26
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	48.72	26.57	12.13	8.47	0.96	0.77	0.96	1.35	1.35	0.96
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	69.41	26.37	12.49	8.33	0.00	0.00	2.08	1.39	2.78	2.08
mesenchymal precursor cell - cardiac, donor1	11752-123G6	48.92	34.33	18.36	6.87	2.75	1.20	2.23	1.54	1.20	1.89
mesenchymal precursor cell - cardiac, donor2	11753-123G7	35.08	23.46	10.24	5.06	1.38	0.92	1.73	0.69	0.46	0.69
mesenchymal precursor cell - cardiac, donor3	11754-123G8	48.01	31.83	9.82	8.09	1.33	0.80	2.92	0.93	0.80	0.93
mesenchymal precursor cell - cardiac, donor4	11755-123G9	54.96	34.71	14.31	12.69	2.43	1.08	4.05	1.76	0.95	1.62
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	44.81	27.60	10.39	7.11	1.71	1.28	1.85	1.00	1.56	0.71
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	49.07	29.31	14.16	4.28	3.29	1.32	2.96	1.32	0.99	0.66
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	35.84	25.88	9.69	7.89	3.18	0.97	1.38	1.11	1.11	0.55
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	34.21	23.39	8.73	9.43	1.40	0.00	1.05	1.75	0.70	0.70
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	48.18	23.68	8.78	5.92	0.82	0.82	0.61	2.04	0.20	0.61
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	29.83	15.46	8.99	6.83	1.44	0.00	1.80	1.80	1.08	1.08
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	33.41	23.59	6.83	6.52	0.93	0.31	1.14	0.83	0.41	1.24
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	39.90	13.45	5.93	3.88	2.96	1.60	2.28	0.68	0.68	1.37
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	74.26	41.54	19.30	12.59	3.36	2.94	3.36	1.68	1.26	1.68
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	40.95	23.61	8.97	6.43	1.94	1.20	1.64	1.34	0.00	0.75
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	42.28	27.57	9.80	6.30	1.31	0.79	1.75	1.23	0.18	1.58
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	37.92	19.51	5.52	3.31	1.47	0.74	1.10	1.47	0.37	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	34.05	17.17	6.01	4.29	1.43	0.00	2.86	0.86	0.00	0.86
mesenchymal stem cell line:Hu5/E18	10568-108B1	51.36	23.16	14.31	7.16	0.84	2.11	1.26	2.53	0.84	0.84
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	22.83	24.20	12.33	9.13	1.37	0.91	1.37	0.46	0.46	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	38.37	29.42	13.05	6.39	1.02	0.00	3.07	1.02	1.53	1.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	30.89	26.18	11.52	6.02	0.52	0.79	0.52	1.05	0.26	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	30.50	23.11	8.93	5.55	1.54	0.62	1.54	0.62	0.00	2.16
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	44.95	28.95	11.77	5.65	1.18	0.24	1.88	0.94	1.65	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	28.77	21.66	13.20	7.45	0.34	1.02	1.35	1.35	1.35	0.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	30.65	25.15	12.58	7.07	1.18	1.57	1.57	1.57	0.79	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	31.97	25.49	16.68	4.17	0.00	0.00	0.46	0.46	2.32	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	96.61	48.30	144.91	48.30	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	41.53	31.44	18.17	5.48	2.31	1.73	2.31	1.44	2.60	0.87
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	35.25	25.21	14.06	4.46	0.45	1.12	1.56	1.56	1.12	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	33.41	28.84	14.66	2.88	0.24	0.48	0.24	1.44	1.44	0.96
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	36.67	28.60	16.13	8.07	2.20	1.47	4.40	0.73	2.93	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	30.21	26.52	15.78	3.69	1.34	0.34	1.34	1.34	1.68	1.01
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	27.84	31.52	11.46	9.01	2.87	0.82	0.41	1.23	0.82	1.23
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	25.34	28.78	14.60	5.58	0.43	0.86	2.58	0.86	1.72	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	35.55	21.88	10.94	0.00	2.73	0.00	2.73	2.73	0.00	5.47
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	15.49	20.66	5.16	0.00	0.00	5.16	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	29.88	21.11	10.07	4.22	1.30	0.97	1.30	1.95	0.97	0.65
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	32.01	23.28	8.73	5.82	1.45	0.00	1.45	2.91	0.00	2.91
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	27.19	19.72	7.46	6.40	1.60	0.53	2.67	0.00	0.53	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	27.80	23.72	5.72	2.45	1.64	0.00	0.82	1.64	2.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	21.77	18.66	9.33	3.50	0.00	0.78	1.17	1.17	1.17	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	27.28	16.79	10.49	4.20	4.20	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	30.80	20.86	9.93	2.98	0.99	0.00	1.99	0.99	0.99	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	28.60	23.84	14.30	4.77	0.00	0.00	0.00	0.00	0.00	4.77
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	23.13	20.16	12.45	4.74	0.59	0.00	2.96	1.19	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	31.68	12.18	6.09	9.75	2.44	0.00	2.44	0.00	0.00	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	27.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	24.07	20.27	9.50	2.53	0.63	0.00	0.63	0.63	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	24.49	15.52	9.31	2.41	0.00	1.38	1.03	1.03	0.69	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	25.79	34.39	10.75	0.00	0.00	2.15	2.15	2.15	4.30	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	15.97	19.96	7.98	0.00	0.00	0.00	0.00	0.00	0.00	7.98
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	30.99	17.22	10.33	0.00	0.00	0.00	0.00	0.00	0.00	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	18.34	16.30	17.11	2.85	1.22	0.81	2.44	0.81	0.41	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	19.86	22.24	16.68	5.56	0.79	0.79	1.59	0.79	0.00	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	16.51	15.92	12.38	2.36	1.18	0.00	0.59	0.00	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	24.31	21.20	16.21	1.25	0.62	0.00	1.56	0.31	0.94	1.25
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	22.72	20.05	8.02	5.35	1.34	0.00	0.00	1.34	2.67	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	22.47	18.92	10.64	3.55	0.00	0.00	2.37	0.00	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	23.11	20.54	10.27	2.57	0.00	0.00	0.00	0.00	2.57	5.14
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	24.78	20.65	14.46	2.75	0.69	0.00	1.38	0.69	0.00	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	46.02	23.75	6.93	4.95	0.00	0.49	1.48	3.46	0.00	1.98
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	31.40	17.94	3.36	2.24	1.12	0.00	1.12	1.12	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	42.62	25.44	6.36	6.36	0.00	1.27	0.64	1.27	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	26.60	20.15	6.45	4.43	2.01	0.40	0.40	2.42	0.00	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	45.79	30.53	2.18	8.72	4.36	0.00	0.00	4.36	0.00	4.36
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	32.94	20.27	5.07	11.40	2.53	1.27	0.00	1.27	0.00	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	29.74	30.95	6.07	3.64	1.82	0.00	0.00	1.82	1.21	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	49.71	18.08	0.00	0.00	0.00	0.00	0.00	4.52	0.00	4.52
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	23.06	19.77	5.77	4.94	0.00	0.00	1.65	1.65	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	36.11	30.16	8.14	5.95	0.60	0.40	0.99	0.99	0.20	0.60
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	27.26	23.36	13.63	4.22	1.30	0.32	0.65	1.62	0.65	1.30
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	30.56	27.50	11.20	6.11	1.02	0.00	1.02	1.02	0.00	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	32.50	29.40	15.47	5.42	0.77	0.00	0.00	0.77	2.32	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	54.81	29.29	9.21	7.32	2.13	0.00	2.60	2.83	0.24	0.47
mesothelioma cell line:ACC-MESO-4	10494-107B8	30.35	9.50	12.74	6.02	8.80	2.32	2.09	0.46	0.93	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	55.56	17.09	8.55	8.55	12.82	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	74.29	21.78	14.90	6.27	4.83	1.85	2.98	2.26	0.72	2.67
mesothelioma cell line:Mero-25	10850-111F4	23.15	14.30	19.97	3.18	7.49	2.95	1.82	1.36	0.68	0.68
mesothelioma cell line:Mero-41	10851-111F5	20.05	13.20	3.18	3.67	0.73	0.24	0.73	0.24	0.00	0.98
mesothelioma cell line:Mero-48a	10852-111F6	29.89	9.96	7.31	3.76	0.66	0.44	0.66	1.55	1.11	0.89
mesothelioma cell line:Mero-82	10853-111F7	39.68	26.02	35.74	3.42	7.10	6.31	1.58	0.79	2.37	1.05
mesothelioma cell line:Mero-83	10854-111F8	70.30	26.72	20.43	6.81	5.62	2.55	2.72	1.87	1.19	1.36
mesothelioma cell line:Mero-84	10855-111F9	26.29	8.34	7.33	2.53	0.00	0.51	0.51	0.25	0.51	0.25
mesothelioma cell line:Mero-95	10856-111G1	49.28	25.67	21.95	6.63	2.48	1.66	0.83	1.04	1.86	1.04
mesothelioma cell line:NCI-H2052	10847-111F1	23.52	9.94	7.29	1.66	1.82	0.83	0.99	1.16	0.00	0.33
mesothelioma cell line:NCI-H226	10846-111E9	37.83	13.03	10.86	4.16	7.78	2.90	2.53	0.90	0.72	0.90
mesothelioma cell line:NCI-H2452	10848-111F2	57.91	30.41	13.32	9.22	3.42	1.37	2.90	1.88	0.51	2.22
mesothelioma cell line:NCI-H28	10845-111E8	35.88	26.72	12.47	8.40	5.09	1.27	1.78	1.27	0.76	1.02
mesothelioma cell line:No36	10857-111G2	27.40	13.05	6.20	4.24	2.94	0.33	0.98	0.00	0.33	0.98
mesothelioma cell line:ONE58	10858-111G3	25.20	7.32	1.63	1.90	2.17	0.00	1.63	2.71	0.27	0.81
migratory langerhans cells, donor1	11901-125F2	20.15	23.61	12.67	4.03	0.38	1.92	0.77	1.34	0.96	0.19
migratory langerhans cells, donor2	11902-125F3	16.24	19.05	10.50	3.42	0.61	0.00	0.37	0.61	0.85	0.12
migratory langerhans cells, donor3	11903-125F4	26.02	23.69	13.46	4.49	0.18	0.18	0.72	0.54	0.54	0.54
mixed mullerian tumor cell line:HTMMT	10689-109F5	42.12	18.94	4.57	3.26	0.98	0.33	0.33	2.29	0.65	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	16.11	7.63	9.75	1.91	0.21	1.91	0.00	0.00	1.27	1.06
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	42.16	18.66	6.68	3.69	1.61	0.23	0.46	1.15	1.15	0.92
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	29.50	30.26	15.98	8.18	2.09	3.81	3.23	0.19	1.14	0.38
myelodysplastic syndrome cell line:SKM-1	10772-110F7	102.74	61.72	9.05	10.53	1.85	0.00	1.48	3.70	0.18	1.66
myeloma cell line:PCM6	10474-106I6	39.73	59.70	9.88	10.28	0.99	0.20	1.98	0.59	0.40	0.59
myxofibrosarcoma cell line:MFH-ino	10600-108E6	39.57	15.22	30.44	2.54	0.00	3.04	0.00	1.01	3.55	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	15.10	12.55	2.75	3.14	0.78	0.20	1.77	0.20	0.00	0.98
nasal epithelial cells, donor1, tech_rep1	12226-129F3	49.81	22.73	6.24	3.68	2.01	0.45	0.78	2.01	0.11	0.33
nasal epithelial cells, donor1, tech_rep2	12226-129F3	56.18	19.19	7.06	4.56	1.03	0.66	1.18	2.79	0.59	0.59
nasal epithelial cells, donor2	12227-129F4	24.29	15.46	14.90	6.07	0.00	2.21	1.10	0.55	1.66	1.10
neuroblastoma cell line:CHP-134	10508-107D4	75.69	90.64	118.02	17.94	20.94	9.66	5.98	1.15	4.83	0.23
neuroblastoma cell line:NB-1	10539-107G8	93.73	89.80	29.93	15.34	2.81	3.37	4.49	3.18	3.37	1.12
neuroblastoma cell line:NBsusSR	10607-108F4	39.23	36.91	7.38	7.80	3.37	1.69	1.27	2.11	0.42	0.84
neuroblastoma cell line:NH-12	10555-107I6	93.73	76.40	39.88	11.55	6.71	5.40	2.05	3.54	2.80	0.19
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	67.61	39.62	20.16	4.51	0.71	0.71	0.71	2.85	0.95	0.71
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	59.55	51.32	22.33	7.44	0.48	0.79	1.74	1.74	0.95	1.43
neuroectodermal tumor cell line:TASK1	10774-110F9	36.63	23.95	7.45	5.23	1.61	0.60	2.42	1.61	1.01	0.40
neuroepithelioma cell line:SK-N-MC	10728-110A8	54.68	15.26	12.72	2.54	0.00	0.64	1.27	1.27	1.27	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	25.29	19.16	13.84	3.73	0.80	0.53	1.06	1.33	1.33	0.00
neutrophil PMN, donor1	12133-128D9	14.87	0.00	14.87	14.87	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	13.28	13.28	0.00	13.28	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	37.88	18.94	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	119.91	69.51	15.73	20.13	1.52	1.52	2.37	3.89	0.68	0.85
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	66.44	77.65	20.01	12.01	4.00	0.80	4.80	1.60	2.40	1.60
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	38.47	31.74	17.63	5.13	1.92	0.64	4.49	0.96	1.60	2.24
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	41.25	31.53	13.66	9.72	2.89	1.58	1.31	1.58	1.05	0.53
nucleus accumbens, adult, pool1	10037-101F1	103.49	67.68	63.09	15.56	2.72	6.00	3.47	5.06	7.97	0.19
occipital cortex - adult, donor10196	10172-103C1	135.99	61.81	111.26	14.42	4.12	10.30	6.18	10.30	4.12	0.00
occipital cortex, adult, donor10252	10163-103B1	78.90	53.67	40.79	12.08	0.27	3.49	1.61	6.71	2.95	0.54
occipital cortex, newborn, donor10223	10355-105E4	99.72	57.87	85.89	16.74	1.09	0.73	6.91	10.55	7.28	1.09
occipital lobe, adult, donor1	10076-102A4	113.09	70.85	80.82	15.48	2.36	6.30	5.25	8.66	5.25	2.89
occipital lobe, fetal, donor1	10073-102A1	93.54	92.26	93.11	11.16	3.43	1.29	3.86	6.87	6.01	2.57
occipital pole, adult, pool1	10036-101E9	73.56	44.23	44.78	10.64	1.66	2.76	1.89	2.92	5.28	0.16
olfactory region, adult	10195-103E6	92.47	59.61	76.23	9.36	2.29	5.16	1.91	7.45	7.26	0.76
optic nerve, donor1	10277-104E7	70.04	58.03	66.03	20.01	0.00	6.00	2.00	0.00	10.01	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	61.05	49.78	14.58	12.99	5.58	5.47	1.59	1.14	1.03	0.80
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	69.11	19.92	12.23	6.05	0.96	0.14	0.69	1.79	0.41	1.24
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	80.26	27.26	27.60	8.47	4.40	2.03	2.37	1.35	1.52	1.86
oral squamous cell carcinoma cell line:SAS	10544-107H4	55.56	21.25	13.98	4.97	2.54	2.19	1.62	0.81	1.96	0.35
osteoclastoma cell line:Hs 706.T	10704-109H2	31.75	27.04	10.88	5.59	1.47	0.29	1.76	1.76	0.29	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	66.34	60.73	17.75	7.47	8.41	0.93	2.80	0.93	1.87	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	67.01	46.65	17.39	11.45	4.24	2.33	4.67	0.85	1.48	0.85
ovary, adult, pool1	10020-101D2	33.54	48.04	19.57	7.77	0.17	0.96	0.96	0.70	1.22	0.26
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	45.65	13.20	12.83	3.30	2.38	1.83	2.93	2.02	2.02	0.18
pancreas, adult, donor1	10049-101G4	21.63	28.22	15.05	4.70	1.88	1.88	0.00	1.88	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	36.34	44.73	36.06	8.39	3.63	3.35	1.40	0.28	0.84	0.56
papillary adenocarcinoma cell line:8505C	10437-106E5	39.35	23.17	3.41	5.96	3.24	0.17	2.56	0.34	0.17	1.19
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	65.07	43.71	9.60	6.95	1.82	0.33	0.99	0.50	0.66	0.83
paracentral gyrus, adult, pool1	10035-101E8	103.88	62.42	67.36	16.20	3.02	8.24	3.48	6.50	8.69	0.92
parietal cortex, adult, donor10258	10373-105G4	112.30	47.71	82.21	8.07	2.94	2.20	2.94	10.28	8.07	0.00
parietal lobe - adult, donor10196	10171-103B9	93.11	65.83	81.82	10.35	1.88	4.70	0.00	12.23	2.82	1.88
parietal lobe, adult, donor10252	10157-103A4	108.03	57.58	51.31	9.98	0.57	3.42	3.42	5.70	7.13	0.57
parietal lobe, adult, pool1	10034-101E7	99.49	60.71	55.25	13.57	2.91	6.96	3.97	5.99	7.23	0.44
parietal lobe, fetal, donor1	10072-101I9	128.02	82.44	88.25	9.70	0.97	0.97	2.91	4.85	1.94	0.97
parietal lobe, newborn, donor10223	10356-105E5	113.28	61.31	105.80	13.09	2.24	5.98	2.62	11.96	5.98	1.12
parotid gland, adult	10199-103F1	54.88	46.87	19.12	8.63	0.00	0.00	1.23	2.47	1.23	1.23
penis, adult	10200-103F2	42.97	51.03	27.39	10.21	0.00	0.00	1.61	0.54	1.61	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	27.52	29.94	15.80	5.58	0.37	0.74	0.74	0.56	0.56	1.12
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	48.81	23.31	14.42	3.64	1.17	2.04	2.33	1.75	1.02	1.02
pineal gland - adult, donor10196	10179-103C8	36.77	37.41	56.76	3.23	1.29	6.45	0.00	4.52	1.29	0.00
pineal gland, adult, donor10252	10160-103A7	96.53	98.90	53.89	14.21	2.37	13.62	3.55	5.33	7.70	2.37
pineal gland, adult, donor10258	10377-105G8	43.27	67.10	58.94	13.80	0.63	10.66	1.25	3.14	5.02	0.00
pituitary gland - adult, donor10196	10180-103C9	81.96	92.07	74.87	11.13	2.02	8.09	3.04	5.06	4.05	3.04
pituitary gland, adult, donor10252	10162-103A9	193.36	150.62	69.84	16.16	1.04	6.78	0.52	7.30	5.21	3.13
pituitary gland, adult, donor10258	10378-105G9	108.11	107.26	51.93	17.02	0.00	5.11	0.00	3.40	5.11	1.70
placenta, adult, pool1	10021-101D3	36.55	49.67	11.29	9.35	2.26	0.75	1.40	0.75	0.65	0.65
plasma cell leukemia cell line:ARH-77	10840-111E3	63.96	22.38	11.39	9.80	2.52	1.72	2.91	5.43	0.53	1.06
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	31.44	18.83	4.82	2.65	0.47	0.62	0.62	0.78	0.16	0.16
pons, adult, pool1	10033-101E6	97.43	55.17	57.15	10.84	4.22	6.28	3.18	4.39	6.11	1.29
postcentral gyrus, adult, pool1	10032-101E5	93.80	55.62	60.59	14.56	2.27	6.63	2.62	5.67	7.50	0.52
promyelocytes/myelocytes PMC, donor1	12132-128D8	31.37	14.64	83.66	2.09	4.18	0.00	0.00	0.00	4.18	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	60.59	38.56	38.56	5.51	5.51	5.51	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	23.47	23.47	23.47	11.74	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	108.96	39.62	15.73	9.76	2.91	1.17	1.17	1.89	0.15	2.91
prostate cancer cell line:PC-3	10439-106E7	51.36	38.66	11.07	9.44	1.45	1.45	1.45	0.91	1.09	1.27
prostate, adult, pool1	10022-101D4	35.28	49.70	16.60	8.07	0.82	0.73	0.91	0.91	1.18	0.54
putamen, adult, donor10196	10176-103C5	144.47	97.02	97.73	15.82	2.12	7.55	4.96	13.46	8.26	1.89
putamen, adult, donor10252	10152-102I8	76.47	64.70	82.35	11.76	1.96	1.96	0.00	3.92	1.96	9.80
putamen, adult, donor10258, tech_rep1	10372-105G3	61.20	40.43	33.88	7.65	2.19	0.00	1.09	14.21	3.28	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	102.44	77.32	76.59	15.22	2.17	2.90	2.42	8.94	5.80	1.21
putamen, newborn, donor10223	10365-105F5	152.93	114.70	77.22	33.73	0.75	5.25	6.00	11.99	4.50	0.75
rectal cancer cell line:TT1TKB	10469-106I1	28.51	23.27	11.93	4.65	2.04	2.04	0.29	0.87	0.58	0.58
rectum, fetal, donor1	10067-101I4	59.81	51.47	33.38	2.78	0.00	4.17	0.00	4.17	0.00	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	33.71	14.63	3.18	4.45	0.85	0.85	0.21	1.70	0.21	0.42
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	32.31	23.20	1.66	7.87	1.24	0.00	3.73	4.56	0.00	0.41
retina, adult, pool1	10030-101E3	48.51	69.88	22.17	9.54	0.50	1.79	1.09	1.29	1.79	0.80
retinoblastoma cell line:Y79	10475-106I7	61.83	47.80	24.94	12.47	4.16	3.64	2.86	2.08	2.34	1.04
rhabdomyosarcoma cell line:KYM-1	10787-110H4	43.65	27.54	18.07	5.04	1.60	3.44	1.72	0.86	2.34	0.98
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	71.71	46.96	32.34	11.53	9.84	6.19	1.97	2.25	4.78	0.84
sacrococcigeal teratoma cell line:HTST	10695-109G2	31.83	20.46	15.16	1.52	0.00	0.00	0.76	0.00	0.76	0.76
salivary acinar cells, donor1	11771-123I7	42.08	27.03	27.03	4.05	2.27	3.08	1.78	0.16	2.10	0.97
salivary acinar cells, donor2	11772-123I8	32.22	26.02	38.14	4.13	1.93	3.17	0.96	1.38	1.65	1.10
salivary acinar cells, donor3	11773-123I9	19.86	20.52	50.32	0.66	0.66	3.31	1.32	0.66	7.28	0.00
salivary gland, adult, pool1	10093-102C3	57.77	48.62	19.45	4.58	2.86	1.14	0.00	2.86	0.57	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	43.42	33.05	13.83	8.43	1.94	0.93	1.10	1.35	1.35	0.34
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	46.43	34.44	16.46	5.76	0.94	2.47	1.65	0.71	1.41	1.29
seminal vesicle, adult	10201-103F3	39.15	58.73	41.27	12.70	1.59	1.06	1.06	1.59	2.12	2.12
serous adenocarcinoma cell line:JHOS-2	10639-108I9	22.11	22.11	9.47	7.04	0.97	1.21	0.73	0.49	0.24	0.49
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	41.02	16.86	4.03	3.52	1.01	0.50	0.50	3.02	0.00	1.01
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	49.17	18.06	7.02	7.02	1.00	1.00	0.00	4.01	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	48.62	32.91	14.24	9.40	6.18	3.63	2.01	0.67	1.07	0.54
signet ring carcinoma cell line:Kato III	10436-106E4	40.23	43.00	7.74	10.06	1.22	0.99	0.88	0.88	0.88	0.55
signet ring carcinoma cell line:NUGC-4	10483-107A6	51.22	48.38	15.74	16.00	2.06	2.71	2.32	0.90	1.55	1.29
skeletal muscle - soleus muscle, donor1	10282-104F3	40.43	47.53	65.97	12.06	7.09	8.51	1.42	2.13	5.67	1.42
skeletal muscle, adult, pool1	10023-101D5	33.58	57.81	20.39	14.39	1.92	1.32	2.16	0.84	1.56	0.36
skeletal muscle, fetal, donor1	10066-101I3	31.16	31.16	21.11	7.04	0.00	2.01	2.01	1.01	1.01	3.02
skin, adult, donor1	10074-102A2	6.79	47.50	20.36	6.79	0.00	0.00	0.00	0.00	6.79	6.79
skin, fetal, donor1	10065-101I2	45.45	47.97	14.52	5.68	1.26	2.52	1.26	3.16	2.52	1.26
small cell cervical cancer cell line:HCSC-1	10800-110I8	54.03	31.68	7.34	5.00	1.00	1.67	1.67	2.00	0.33	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	52.95	49.17	26.48	7.25	4.10	5.67	3.15	1.89	1.58	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	53.78	25.64	6.17	4.24	0.77	0.39	0.58	3.08	0.96	0.77
small cell lung carcinoma cell line:LK-2	10541-107H1	58.18	48.95	34.61	14.50	3.79	5.77	2.47	0.66	1.98	1.65
small cell lung carcinoma cell line:NCI-H82	10842-111E5	71.10	17.37	9.01	6.76	3.06	2.09	2.73	7.56	1.13	0.32
small cell lung carcinoma cell line:WA-hT	10562-108A4	51.21	59.93	54.48	9.37	4.58	21.36	3.05	1.31	6.10	0.44
small intestine, adult, pool1	10024-101D6	47.78	54.23	22.93	19.59	2.63	1.19	5.49	2.03	1.43	1.43
small intestine, fetal, donor1	10064-101I1	39.80	55.53	35.38	8.60	2.95	1.47	2.95	0.74	0.25	0.49
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	27.70	30.26	10.77	8.72	0.00	1.03	1.03	1.54	0.51	1.03
smooth muscle, adult, pool1	10048-101G3	22.23	49.11	31.27	6.72	0.00	0.26	0.78	1.03	0.78	0.26
somatostatinoma cell line:QGP-1	10781-110G7	26.53	32.97	27.87	7.50	1.61	3.48	2.68	0.54	3.22	0.00
spinal cord - adult, donor10196	10181-103D1	90.62	58.50	63.09	9.18	2.75	2.98	2.98	7.34	2.98	1.38
spinal cord, adult, donor10252	10159-103A6	60.72	59.93	31.94	16.17	2.76	3.15	0.79	2.76	1.18	0.79
spinal cord, adult, donor10258	10369-105F9	84.40	78.17	78.17	7.61	9.69	4.15	4.84	11.07	4.15	1.38
spinal cord, fetal, donor1	10056-101H2	63.42	53.06	51.84	14.03	1.83	7.32	3.05	4.88	3.66	1.83
spinal cord, newborn, donor10223	10359-105E8	100.57	70.72	55.11	12.86	6.89	4.13	2.76	5.51	6.89	4.13
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	23.90	18.22	13.59	4.48	1.79	0.45	1.34	0.90	1.34	0.00
spleen, adult, pool1	10025-101D7	38.55	35.57	9.80	6.61	0.55	1.21	1.65	0.22	0.77	0.66
spleen, fetal, pool1	10044-101F8	31.31	24.23	6.99	4.13	0.79	1.27	0.64	0.95	0.48	0.08
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	52.38	27.95	10.14	9.21	3.00	3.21	2.28	1.35	0.83	0.93
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	46.14	34.18	17.85	6.46	2.09	1.71	1.33	1.71	1.52	0.38
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	73.73	62.55	34.60	13.63	4.19	1.05	0.35	0.35	1.40	2.45
squamous cell carcinoma cell line:T3M-5	10616-108G4	60.59	18.76	10.56	2.74	4.30	1.56	0.39	1.17	0.78	1.17
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	50.43	37.14	20.26	6.08	1.24	2.70	0.79	0.45	1.80	1.01
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	21.60	14.40	6.35	4.24	1.69	0.00	1.69	1.69	0.00	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	44.85	41.04	13.12	16.08	5.92	0.85	2.12	0.00	0.42	0.42
stomach, fetal, donor1	10062-101H8	46.99	45.92	41.65	5.34	1.07	2.14	1.07	0.00	3.20	1.07
submaxillary gland, adult	10202-103F4	46.14	42.16	18.23	6.84	0.57	0.00	0.57	1.71	1.71	1.14
substantia nigra - adult, donor10196	10178-103C7	54.27	54.27	54.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	64.18	57.53	40.50	9.55	4.15	4.36	3.53	3.95	2.28	1.25
substantia nigra, adult, donor10258	10371-105G2	92.59	50.17	80.17	8.28	8.28	8.79	1.03	10.86	6.21	1.03
substantia nigra, newborn, donor10223	10358-105E7	55.82	36.74	40.27	10.60	2.12	0.00	0.71	11.31	4.24	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	59.61	52.96	25.91	11.92	1.38	2.52	3.21	0.69	1.83	0.69
temporal lobe, adult, pool1	10031-101E4	79.43	43.91	51.03	12.38	2.12	3.56	2.03	4.32	4.41	0.68
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	108.26	94.73	69.80	12.82	2.14	2.85	2.14	8.55	6.41	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	76.48	61.54	61.97	10.55	1.76	2.64	2.64	4.40	1.32	1.76
tenocyte, donor1	11763-123H8	45.03	25.14	19.20	6.63	2.44	2.79	1.05	0.70	1.05	2.09
tenocyte, donor2	11765-123I1	39.68	26.32	15.26	3.82	0.76	0.00	2.29	1.14	0.76	0.76
tenocyte, donor3	11768-123I4	42.26	27.06	17.79	4.08	2.59	0.37	1.11	1.85	1.11	1.11
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	26.51	23.96	36.03	5.10	5.10	2.38	1.36	2.55	0.85	0.17
teratocarcinoma cell line:NCR-G1	10798-110I6	63.35	26.82	13.26	4.32	2.16	4.62	2.62	1.08	1.85	0.46
teratocarcinoma cell line:PA-1	10807-111A6	59.67	26.66	22.32	4.65	2.01	1.55	1.55	2.79	1.08	0.62
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	26.41	15.87	74.90	3.94	4.32	2.16	1.27	1.02	2.54	0.51
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	58.99	41.60	57.10	7.94	6.05	2.27	0.38	1.89	4.16	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	28.36	33.59	50.06	6.43	4.04	3.60	1.09	0.87	2.73	0.22
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	41.04	38.11	40.39	8.47	3.26	0.33	0.98	0.65	1.63	0.65
testis, adult, pool1	10026-101D8	47.57	57.23	24.48	11.17	1.50	2.58	1.83	0.75	2.25	1.07
testis, adult, pool2	10096-102C6	68.56	47.82	28.87	6.77	0.45	2.71	0.90	3.61	2.26	1.80
thalamus - adult, donor10196	10168-103B6	82.80	44.16	71.76	7.73	4.42	3.31	2.21	3.31	4.42	0.00
thalamus, adult, donor10252	10154-103A1	64.70	66.42	39.07	11.25	2.97	3.91	1.56	3.59	2.50	0.94
thalamus, adult, donor10258, tech_rep1	10370-105G1	72.36	52.35	49.27	3.08	27.71	7.70	4.62	18.48	4.62	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	69.99	50.07	35.08	8.73	3.46	2.64	2.80	6.26	2.64	0.82
thalamus, newborn, donor10223	10366-105F6	101.83	50.63	60.98	14.38	5.75	6.33	2.30	14.38	6.90	0.00
throat, adult	10209-103G2	43.94	50.18	19.97	10.24	1.25	0.50	1.00	1.00	1.25	1.00
throat, fetal, donor1	10061-101H7	53.02	54.24	35.35	7.01	0.61	1.22	1.22	3.96	2.44	1.22
thymic carcinoma cell line:Ty-82	10803-111A2	52.86	33.59	29.81	9.74	0.79	2.58	1.39	1.59	1.59	0.79
thymus, adult, pool1	10027-101D9	63.72	39.67	14.81	8.65	0.40	0.40	0.99	1.79	1.09	1.39
thymus, fetal, pool1	10043-101F7	64.73	38.65	12.47	8.00	0.62	1.04	1.45	2.81	0.62	0.42
thyroid carcinoma cell line:KHM-5M	10776-110G2	35.63	13.30	4.79	7.58	1.86	0.27	2.79	2.13	0.27	0.80
thyroid carcinoma cell line:TCO-1	10783-110G9	39.53	16.06	6.01	3.63	2.37	0.70	2.79	1.12	0.70	0.84
thyroid, adult, pool1	10028-101E1	64.67	64.01	27.81	13.90	1.03	1.77	2.24	2.52	2.33	0.84
thyroid, fetal, donor1	10060-101H6	58.53	59.32	59.59	8.96	0.53	4.22	2.11	1.85	5.27	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	18.48	24.64	40.04	0.00	0.00	6.16	3.08	0.00	3.08	0.00
tongue, adult	10203-103F5	41.17	55.82	20.23	11.86	0.70	1.63	3.49	0.23	1.63	2.56
tongue, fetal, donor1	10059-101H5	45.71	60.30	22.86	7.09	0.39	1.97	3.15	1.97	1.18	2.36
tonsil, adult, pool1	10047-101G2	42.88	37.17	9.42	7.81	0.30	0.50	1.10	1.40	1.40	0.70
trachea, adult, pool1	10029-101E2	39.02	37.71	12.84	9.82	0.74	0.25	1.47	1.39	1.06	0.82
trachea, fetal, donor1	10058-101H4	49.63	57.70	29.62	5.39	0.38	0.77	1.54	1.15	1.54	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	23.03	22.32	8.86	6.38	2.13	0.00	3.54	0.71	0.71	0.71
transitional-cell carcinoma cell line:5637	10418-106C4	38.30	18.34	4.15	6.28	2.23	1.22	1.42	1.11	0.71	0.41
transitional-cell carcinoma cell line:JMSU1	10492-107B6	43.72	43.40	12.06	7.83	2.35	0.63	2.51	1.41	0.63	0.78
tridermal teratoma cell line:HGRT	10694-109G1	53.27	28.54	22.83	7.61	0.00	0.00	1.90	0.00	1.90	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	50.62	43.00	16.85	10.16	2.88	1.10	3.72	0.85	0.51	1.19
umbilical cord, fetal, donor1	10057-101H3	25.04	31.30	10.43	4.17	0.00	0.00	0.00	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	43.00	61.77	31.05	13.65	0.51	0.85	0.68	1.54	1.71	0.17
uterus, fetal, donor1	10055-101H1	47.61	55.29	28.67	7.68	0.00	1.02	2.05	2.56	1.54	1.02
vagina, adult	10204-103F6	22.62	20.68	5.17	2.58	0.00	0.00	0.00	1.94	0.00	0.00
vein, adult	10191-103E2	37.92	40.11	16.22	7.23	1.10	0.22	1.10	0.44	0.66	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	34.71	15.76	7.21	5.07	1.87	0.53	0.27	2.40	0.53	0.80